All Projects


2012 Olympics Anti-Doping Laboratory

The 2012 London Olympics is the first Olympic event to have an anti-doping laboratory sponsored by a pharmaceutical company after GlaxoSmithKline (GSK) proposed to sponsor the anti-doping programme.

3B Blackbio Biotech India Manufacturing Plant, India

The Indo-Spanish joint venture (JV) company 3B Blackbio Biotech India opened a new biotech plant in Bhopal, Madhya Pradesh state in April 2011.


Abbott Laboratories Biotech Facility, Puerto Rico

Puerto Rico has a growing reputation as a biotech and pharmaceutical hub ('Bio Island') and plays host to manufacturing facilities from the world's largest pharmaceutical companies.

ABC Laboratories, Pharmaceutical Facility – Discovery Ridge, USA

Analytical Bio-Chemistry (ABC) Laboratories Inc is a major privately owned contract research organisation in the US. The

Abcam Global Headquarters, Cambridge

In June 2017, UK-based life sciences company Abcam began building its new global headquarters building at the Cambridge Biomedical Campus (CBC) in Cambridge, UK.

AbCellera Biologics’ GMP Manufacturing Facility, Vancouver, Canada

Canadian biotechnology firm AbCellera Biologics is to build a good manufacturing practice (GMP) antibody manufacturing facility in Vancouver.

Abzena’s Biotherapeutics Manufacturing Facility Relocation, San Diego

Abzena is expanding its biotherapeutics manufacturing operations by relocating to a new leased facility in Lusk Boulevard, San Diego, US.

Abzena’s cGMP Biologics Manufacturing Facility, Sanford, North Carolina

Abzena is expanding its cGMP biologics manufacturing capacity by opening a 120,000ft² facility in Sanford, North Carolina.

Accucaps Industries, Manufacturing Capacity – Canada

Accucaps Industries is a contract manufacturer for the soft gelatine encapsulation of pharmaceutical and nutritional compounds based in North America. The company has been in operation since 1989.

Achillion Pharmaceuticals Biotech Facility

Achillion Pharmaceuticals was founded in February 2000 as one of the largest biotech start-ups in the USA.

Acino Rivastigmine Patches Manufacturing Plant, Miesbach

Acino opened a new pharmaceutical manufacturing plant in Miesbach, Germany, in August 2012. The plant, owned and managed by Acino Holding, produces commercial quantities of transdermal rivastigmine patches.

Aenova’s Biologics and Vaccines Manufacturing Facility Expansion, Latina, Italy

Aenova’s existing site in Latina has been equipped with a sterile fill and finish area for vials and prefilled syringes (PFSs).

Aeroton Adcock Ingram Critical Care (AICC) Factory, Gauteng

The Adcock Ingram Critical Care (AICC) factory is an integrated pharmaceutical manufacturing and medical-grade plastics production facility in Aeroton, South Africa.

Aesica Containment Facility

Aesica, a supplier of active pharmaceutical ingredients, opened a new High Capacity Manufacturing facility at its Queenborough site in September 2013.

Affymetrix Inc, Manufacturing Facility – Singapore

Affymetrix Inc was one of the pioneering companies in genetic microarray technology in the 1980s. It now manufactures pr

AGC Biologics’ Manufacturing Facility Expansion, Heidelberg, Germany

AGC Biologics expanded its Heidelberg site with plasmid DNA (pDNA) and messenger RNA (mRNA) production line in October 2023.

Agendia Genomics Laboratory California

Agendia, a genomics cancer diagnostics company, opened a new clinical genomics laboratory on 5 August 2010. Located in

Agilent Technologies’ Pharmaceutical Facility, Frederick, Colorado

US-based analytical technology company Agilent Technologies has opened a multi-structure pharmaceutical manufacturing plant in Frederick, Weld County, Colorado. The facility's construction began in October 2016 and it was opened in June 2019.

Agilent’s Nucleic Acid-Based Therapeutics Manufacturing Facility, Colorado, USA

Agilent is investing $725m to double its therapeutic nucleic acids manufacturing capacity in Frederick, Colorado, by 2026.

AGORA Cancer Centre, Lausanne

The AGORA cancer centre is being built at the Lausanne University Hospital site next to Lake Geneva, Switzerland.

Akron Biotechnology’s Ancillary Materials Manufacturing Facility, Sarasota, Florida, US

Akron Biotechnology is developing a manufacturing facility in the city of Sarasota in Florida, US to produce cell and gene therapy materials and technologies.

Albert Sherman Center, UMMS

The University of Massachusetts Medical School (UMMS), the US, expanded its research and curriculum teaching capabilities with the opening of the new Albert Sherman Center in January 2013.

Alcami’s Analytical Testing Facility, St Louis, Missouri

US-based pharmaceutical company Alcami has relocated its existing analytical testing facility in Missouri to the Cortex Innovation Centre in Central West End, St Louis.

Alcon Pharmaceutical Facility, Singapore

A Swiss pharmaceutical company founded in 1945, Alcon manufactures and markets pharmaceuticals, surgical equipment and devices, contact lenses and other vision care products.

Aldevron GMP Plasmid Manufacturing Facility, Fargo, North Dakota, US

In March 2018, US-based biotechnology company Aldevron began construction of a good manufacturing practice (GMP) compliant plasmid manufacturing facility in Fargo, North Dakota.

Alewife Research Centre (ARC), Cambridge, Massachusetts

The Davis Companies (TDC), a US-based real estate firm, has developed the Alewife Research Centre (ARC), a research centre in West Cambridge, Massachusetts.

Alexion Pharmaceuticals Global Headquarters, New Haven

In June 2013, US-based pharmaceutical company Alexion Pharmaceuticals began building its new global headquarters in New Haven, Connecticut.

Allergan Manufacturing Facility Expansion, Waco, Texas

Ireland-based pharmaceutical company Allergan, which produces eye-care and dermatological products, began an expansion of its manufacturing facility in Texas Central Park in Waco, Texas, in April 2016.

Almac Commercial Manufacturing Facility

Global pharmaceutical services provider Almac Group completed the expansion of its commercial pharmaceutical manufactu

Alnylam’s Manufacturing Facility, Norton, Massachusetts

Alnylam Pharmaceuticals has constructed a new manufacturing facility in Norton, Massachusetts, US. The company broke ground on the $200m facility on 28 April 2016 and completed the build in January 2020.

Altana Pharma Solid Dosage Finishing Plant

The Altana Pharma solid dosage plant in Carrigtwohill, County Cork, Republic of Ireland, is owned by Gilead Sciences. Gi

Althea Technologies Biologics Manufacturing Facility, San Diego

Althea Technologies has launched a commercial-scale GMP manufacturing facility in Sorrento Valley area, a major biotechnology hub in San Diego, California.

Altman Clinical and Translational Research Institute (CTRI), San Diego

In January 2013, the University of California, San Diego (UCSD) began building the Altman Clinical and Translational Research Institute (CTRI) building at La Jolla in San Diego, California.

Alvotech Biosimilar Manufacturing Facility, Reykjavik

Iceland-based biopharmaceutical company Alvotech officially opened a biosimilar facility in Reykjavik on 8 June 2016. The facility will be dedicated to the production of biosimilars of monoclonal antibodies (mAbs).

Amgen Helix Project

The Helix Project is a major research and development facility constructed by Amgen (ex Immunex) in Seattle. It is calle

Amgen Pharmaceutical Manufacturing Facility

West Greenwich, Rhode Island, US, is the site of a new pharmaceutical manufacturing facility dedicated to the production

Amgen Process Development Facility

Bothell is the site of a process development facility owned by the pharmaceuticals firm Immunex (now owned by Amgen).

Amgen’s Drug Substance Manufacturing Plant, Wake County, North Carolina

Amgen will build its second manufacturing facility in the US to support rising demand for its drugs, with a $550m investment.

Amgen’s Manufacturing Facility Expansion, Dun Laoghaire, Ireland

US-based biotechnology company Amgen opened its newly expanded manufacturing facility in Dun Laoghaire, Ireland, in August 2015.

Amgen’s New Bio-manufacturing Plant, Rhode Island, US

US-based biopharmaceutical company Amgen is developing a bio-manufacturing facility at its campus in West Greenwich, Rhode Island, US.

Amicus Therapeutics’ Global Research and Gene Therapy Centre, Philadelphia

Amicus Therapeutics built a global research and gene therapy centre of excellence in Philadelphia, Pennsylvania, US.

AMRI cGMP Manufacturing Sterile Fill and Finish Facility

Albany Molecular Research (AMRI) operates a cGMP manufacturing sterile fill and finish facility in Burlington, Massach

Amway Nutrilite Vitamins Manufacturing Facility, Ada, Michigan

US-based direct-selling company Amway started building a Nutrilite® production facility near Ada, Michigan, in May 2013.

Amway NUTRILITE® Botanical Concentrate Manufacturing Facility

Amway, a direct-selling company based in the US, is constructing a new manufacturing facility at Quincy in Washington, US, for its NUTRILITE® Botanical Concentrates.

Amylin Pharmaceutical – West Chester, Ohio, USA

Amylin Pharmaceuticals is a biopharmaceutical firm located in San Diego, California, with over 1,000 employees in the US

Aphena Pharma’s Solid Dose Division Expansion, Cookeville, Tennessee

Aphena Pharma expanded its solid dose division in Cookeville, Tennessee, by increasing its bottle packaging capacity.

Aptar Pharma’s Manufacturing Facility, Navi Mumbai

Aptar Pharma, which is part of the AptarGroup, inaugurated its new manufacturing site in Mumbai, the commercial capital of India.

Aragen’s Biologics Manufacturing Facility, Bangalore, India

Aragen Life Sciences will invest $30m to set up a new biologics manufacturing facility in India.

Argonne National Laboratory’s Advanced Protein Crystallisation Facility

Argonne National Laboratory is building a new advanced protein crystallisation facility (APCF) in Illinois, US. The $34.5m facility will help scientists across the world.

Argos Therapeutics Biomanufacturing Facility, Durham, North Carolina

In October 2014, US-based biopharmaceutical company Argos Therapeutics began building a biomanufacturing facility at Research Triangle Park in Durham, North Carolina.

Arranta Bio’s Boxborough Facility, Massachusetts

Arranta Bio, a US-based microbiome contract development and manufacturing organisation (CDMO), is building a manufacturing facility in Boxborough, Massachusetts.

Arranta’s New Commercial-Ready Manufacturing Facility, Watertown, Massachusetts

Arranta Bio is constructing a new multi-product, commercial-ready manufacturing facility in Watertown, Massachusetts, US.

Arrowhead Pharmaceuticals’ New Manufacturing and Laboratory Facilities, Verona, Wisconsin, USA

Arrowhead plans to invest up to $250m to construct a new manufacturing plant and associated lab facilities in Verona.

Artiva Biotherapeutics’ NK Cell Therapy Research and GMP Manufacturing Facility, San Diego, USA

Artiva’s San Diego manufacturing facility will bolster its NK cell therapy pipeline development and supply chain for clinical studies.

Ash Stevens Riverview Facility

Michigan-based contract pharmaceutical manufacturing company Ash Stevens operates two facilities for API process development and production.

Aspen Pharma’s High-Containment Manufacturing Facility, Port Elizabeth

In May 2018, pharmaceutical manufacturing firm Aspen Pharma opened a high-containment facility in Port Elizabeth, South Africa.

Astellas Institute for Regenerative Medicine Relocation

Japanese pharmaceutical company Astellas Pharma has announced plans to relocate its wholly-owned US subsidiary, Astellas Institute for Regenerative Medicine (AIRM), in December 2017.

Astellas Pharma’s New Manufacturing Facility, Toyama

Astellas Pharma unveiled its plans to construct an active pharmaceutical ingredient (API) manufacturing facility in Toyama, Japan, in January 2020.

AstraZeneca API Manufacturing Facility, Dublin, Ireland

AstraZeneca’s API plant will manufacture small molecules for drugs in late-stage development and early marketing.

AstraZeneca API Manufacturing Plant, Bristol, UK

AstraZeneca opened a manufacturing plant at their Bristol site in May 2003. The plant required a total investment of $145m (£90m) over a period of four years.

AstraZeneca Biologics Manufacturing Facility, Södertälje

Anglo-Swedish pharmaceutical group AstraZeneca is developing a state-of-the-art facility for manufacturing biological medicines in Södertälje, Sweden.

AstraZeneca Biopharmaceutical Manufacturing

DSM Biologics completed the construction of the first phase of a substantial expansion to its large-scale biopharmaceuti

AstraZeneca Large Scale Laboratory (LSL) Facility, Macclesfield, UK

AstraZeneca's large-scale laboratory (LSL) project was instigated as a brownfield development in Macclesfield, UK.

AstraZeneca Pharmaceutical Manufacturing Plant, Wuxi, Shanghai, China

In early 2001, AstraZeneca inaugurated a pharmaceutical plant in the Wuxi region of northeastern China.

AstraZeneca Pharmaceuticals Complex, Södartälje, Sweden

The project is a pharmaceuticals plant located at Snackviken, in Södartälje, Sweden. It is owned by AstraZeneca, which was formed by a merger of Swedish Astra and British Zeneca.

AstraZeneca R&D Centre and Corporate Headquarters, Cambridge, UK

AstraZeneca built its global R&D centre and corporate headquarters at the Cambridge Biomedical Campus with a $1.3bn investment.

AstraZeneca R&D Facility, Alderley Park, Cheshire

AstraZeneca's Alderley Park site is the company's largest R&D facility. Located in the middle of Cheshire in the nor

AstraZeneca Solid Forms Production Plant, Cairo, Egypt

AstraZeneca's pharmaceutical production facility in Sixth of October City (Madinat Sittah Uktubar), near Cairo, produces

AstraZeneca Symbicort Production Facility, Dunkirk

AstraZeneca France's Dunkirk plant has been sold to Minafin, a subsidiary of the Minakem Group. The acquisition was comp

AstraZeneca’s Bulk Pharmaceutical Purification Plant, Guayama, Puerto Rico

In July 1997, AstraZeneca announced plans to invest £15m in its Guayama facility in Puerto Rico.

AstraZeneca’s Manufacturing Facility, North Ryde, Sydney

AstraZeneca’s manufacturing facility in North Ryde, Sydney, Australia is involved in the production and export of medicines, and has been operational for more than 60 years.

AstraZeneca’s New Manufacturing Facility, Taizhou

AstraZeneca started production at its a new manufacturing facility at Taizhou in Jiangsu province of China in October 2014. The facility manufactures intravenous and oral solid medicines for the Chinese market.

Athenex Biotech Plant, Dunkirk, New York

US-based pharmaceutical company Athenex, in partnership with the State University of New York Polytechnic Institute (SUNY Polytechnic Institute), is building a high pharmacy oncology manufacturing facility in Dunkirk, New York, to manufacture sterile high-potency oncology drugs.

ATMI Bloomington Manufacturing Facility

ATMI LifeSciences completed a $45.5m (€34.8m) expansion to its manufacturing facility in Bloomington, Minnes

AtomVie Global Radiopharma’s Radiopharmaceutical Facility, Ontario, Canada

AtomVie will build a new facility in Canada to expand radiopharmaceutical production capacity by more than ten times.

Audentes’ Gene Therapy Manufacturing Facility, North Carolina, US

The facility is located at 6074 Enterprise Park Drive within Central Carolina Enterprise Park in Sanford, Lee County, North Carolina.

Autolus Therapeutics’ CAR-T Cell Manufacturing Facility, Stevenage, UK

Thefacility expected to process 2,000 treatments each year and generate 400 job opportunities in Stevenage.

Avantor’s Life Sciences Research Centre, New Jersey

Avantor Performance Materials has opened a life sciences research centre in Bridgewater, New Jersey.

Aventis Recombinant

Early in 2003, Aventis Pharma Germany completed their third insulin plant in Frankfurt, Germany. The new plant produces

Aventis’ Enoxaparin Sodium Manufacturing Plant, Jurong Island, Singapore

Aventis' Jurong Island facility for the manufacture of enoxaparin sodium was opened in July 1999.

AveXis Gene Therapy Manufacturing Facility, North Carolina, US

AveXis is investing an additional $60m in its new gene therapy manufacturing facility in Durham County, North Carolina, US.


B Braun Medical Infusion Technology Facility

B Braun opened its infusion technology facility at its global headquarters in Melsungan, Germany, on 02 June 2010.

Bactolac Pharmaceutical Facility, New York

Bactolac Pharmaceutical's new manufacturing facility in New York, US, is located alongside its existing facility in Haup

BASi Discovery Center, Indiana

Bioanalytics Systems, also known as BASi, is a US-based pharmaceutical research company. It offers contract laboratory services to pharmaceutical companies.

Bavarian Nordic Smallpox Vaccine Facility

The Danish biotech company Bavarian Nordic has set up a new smallpox vaccine production facility in Kvistgård, Nort

Baxalta Biologics Facility, Georgia, US

US-based biopharmaceutical company Baxalta, a spin-off of Baxter International, began building a biologics facility in Georgia, US, in August 2012.

Baxter BioPharma Solutions Parenteral

Baxter BioPharma Solutions is a contract manufacturer of pre-filled syringes, vials and cartridges for the packaging of vaccines and drugs to treat chronic conditions such as rheumatoid arthritis and multiple sclerosis.

Baxter Cytotoxic Contract Manufacturing Facility

Baxter Biopharma Solutions is expanding its cytotoxic manufacturing facility in Halle in Westfalen, Germany. It is one

Baxter Healthcare Cartago Facility

Baxter International is a diversified healthcare company with a presence in several countries. The company is segmented

Baxter R&D Facility

Baxter's new research and development facility was launched in June 2010 in Belgium.

Bayer Corporation Biotechnology Plant, Berkeley, California, US

In August 2000, the Bayer Corporation was granted permission by the city of Berkeley to develop an additional 14 acres s

Bayer Healthcare Cell Biology Centre, Wuppertal

Bayer Healthcare broke ground for a new biopharmaceutical manufacturing facility in Wuppertal, Germany on 13 December

Bayer Healthcare Pharmaceuticals Plant, Snohomish County, Washington State

Berlex Laboratories LLC based in Bothell, Washington was the US subsidiary of the German pharmaceutical company Schering

Bayer Healthcare Pharmaceuticals R&D Centre

Bayer Healthcare Pharmaceuticals opened an R&D facility in San Francisco, California, US, in January 2011.

Bayer’s Cell Therapy Manufacturing Facility, California, USA

Bayer’s cell therapy manufacturing facility in Berkeley, California, supports regenerative medicines production on a global scale.

Bayer’s Cell Culture Technology Centre, California, US

Bayer is building a cell culture technology centre in California for the development of biological therapies.

Bayer’s New Contraceptive Production Facility, Turku, Finland

German multinational pharmaceutical and life sciences company Bayer is building a contraceptive production facility in Turku, Finland.

Bayer’s Solida-1 Pharmaceutical Production Facility, Leverkusen, Germany

Bayer is developing the Solida-1 pharmaceutical facility in Leverkusen, Germany, to produce solid pharmaceutical products.

BD Biosciences Production Facility

BD Biosciences, a division of the New Jersey based medical technology company BD (Becton, Dickinson and Company), laun

BeiGene Biologics Manufacturing Facility, Guangzhou, China

BeiGene Biologics, a joint venture (JV) of BeiGene Hong Kong and Guangzhou GET Technology Development, is developing a biologics manufacturing facility in Guangzhou in China's Guangdong province.

BeiGene’s New Manufacturing and Clinical R&D Centre, Hopewell, USA

BeiGene's new manufacturing and clinical R&D centre in Hopewell, New Jersey, will focus on developing novel cancer medications.

Beike Biotechnology Stem Cell Storage and Processing Facility, Jiangsu

Beike Biotechnology, in association with Jiangsu Government's China Medical City, has opened a stem cell storage and

Berkshire Sterile Manufacturing Facility Expansion, Lee, Massachusetts

Berkshire Sterile Manufacturing (BSM) is expanding its manufacturing facility in Lee, Massachusetts.

Bharat Biotech, Vaccine Production Plant, Perak

With the ascendancy of the Indian pharmaceutical and biotech industries has come expansion and, in some cases, foreign i

Bidachem Active Pharmaceutical Ingredients Plant, Bergamo

Bidachem SPA is one of the major manufacturers of fine chemicals and active pharmaceutical ingredients (APIs) in Italy.

Bigelow Centre for Blue Biotechnology

The Bigelow Centre for Blue Biotechnology, (BCBB) is a new research centre built in East Boothbay, Maine, US. It conducts frontline research on applying the ocean's microbial ecosystems to biopharmaceuticals.

BioBAT Bioscience Center

BioBAT, a research and biomanufacturing project, is a non-profit partnership between New York City Economic Development

BioCentriq Cell and Gene Therapy Manufacturing Centre, Newark, US

BioCentriq is a clinical manufacturing facility for cell and gene therapies under development at the New Jersey Institute of Technology (NJIT) university in Newark, New Jersey, US, the first cell and gene therapy development and manufacturing centre established on a university campus in the country.

BioCina’s Biologics Manufacturing Facility, Adelaide, Australia

BioCina has opened Australia’s first bacterial cell-based facility that meets regulatory criteria for medicinal products.

Biodesign C Research Building, Arizona State University, Tempe, Arizona

In September 2018, Arizona State University (ASU) officially opened its Biodesign C research building at the Biodesign Institute complex in Tempe, Arizona, US.

Biogen Idec Pharmaceutical Production Facility

In March 2003 Biogen Idec began construction of its first production facility to be located outside of the USA. The plan

Biogen’s Biologics Manufacturing Facility, Solothurn, Switzerland

Biogen's biologics manufacturing facility in Luterbach near Solothurn, Switzerland, was opened in 2021

Biolab Research and Development Centre, Mississauga

Brazilian pharmaceutical firm Biolab Farmacêutica has opened a research and development (R&D) centre in Mississauga in the Greater Toronto Area (GTA) of Ontario, Canada.

Biolex Therapeutics Facility Expansion, Pittsboro, North Carolina

Biolex Therapeutics is a biotech company involved in the development and commercialisation of complex proteins and monoc

BioMalta Life Sciences Park, San Gwann, Malta

BioMalta is a state-of-the-art life sciences park in San Gwann, Malta, sponsored by the Maltese Government.

BioMarin cGMP Manufacturing Facility

BioMarin Pharmaceutical is a biotechnology firm headquartered in Novato, California. The company's operations in Novat

Biomedical Engineering and Advanced Manufacturing Centre, Ontario, Canada

The Biomedical Engineering and Advanced Manufacturing (BEAM) centre is located in McMaster Innovation Park in Hamilton, Ontario.

Biomedicum Research Laboratory, Karolinska Institute

Biomedicum is one of the largest experimental biomedical research laboratories in Europe.

Bioniche Life Sciences’ Vaccine Manufacturing Facility, Belleville, Ontario

Canada-based biopharmaceutical company Bioniche Life Sciences launched a new livestock manufacturing facility on 29 Ap

Bionova’s GMP Biologics Manufacturing Facility, Fremont, California

Bionova’s Fremont manufacturing facility produces clinical supply for clients using mammalian cell culture trains.

BioNTech mRNA Vaccine Manufacturing Facility, Rwanda

BioNTech is building its first manufacturing facility in Kigali, Rwanda, to support the production of mRNA vaccines in Africa.

BioNTech’s COVID-19 Vaccine Manufacturing Facility, Marburg

BioNTech’s manufacturing site in Marburg, Germany, will be used for the production of its Covid-19 vaccine candidate, BNT162.

Biopol Allergy Immunotherapy Manufacturing Facility, Idaho

Biopol Laboratory, a subsidiary of the ALK-Abelló Group, completed the construction of a new manufacturing and rese

Biopolis Biomedical Research Hub, Buona Vista

Biopolis is a custom-built biomedical research and development (R&D) hub at One-North, Buona Vista, Queenstown, Singapore. Covering 183ha of land, the hub is aimed to benefit a range of disciplines.

Biosciences Partnership Building, Phoenix, Arizona

In October 2014, the University of Arizona (UA) College of Medicine in Phoenix, Arizona, broke ground on the Biosciences Partnership Building research facility.

Biosite HQ and Manufacturing Campus, Mera Misa, California

The Biosite headquarters and manufacturing unit in Mera Misa, San diego, California was completed in August 2006. Biosi

BioSolutions New Manufacturing Facility

Emergent BioSolutions launched a new biotechnology manufacturing facility on 16 July 2010. Formerly known as the MdBio

BIOVECTRA mRNA Vaccine and Biomanufacturing Centre, Charlottetown, Canada

The facility is pivotal to the company’s expansion plans to create an end-to-end solution for producing vaccines and therapies.

BioVectra’s Biologics Manufacturing Facility Expansion, Canada

In March 2019, BioVectra announced plans to expand its biologics manufacturing facility in Windsor, Nova Scotia, Canada.

Bipha Human Serum Albumin Plant, Hokkaido, Japan

The Chitose project is a human serum albumin (HSA) production plant that uses a genetic biologic recombination process.

Blu Pharmaceuticals Facility

Kentucky-based generic drug sales and distribution company Blu Pharmaceuticals opened a new facility in the town of Do

Boehringer Ingelheim

In March 2002 Boehringer Ingelheim opened their new manufacturing facility in Pudong, Zhangjiang High Tech Park in Shang

Boehringer Ingelheim Active Ingredients Plant

Boehringer Ingelheim officially opened the new active ingredients plant in Ingelheim in early 2003. The plant will be ab

Boehringer Ingelheim Biologicals Development Centre (BDC), Biberach, Germany

The state-of-the-art biologicals development centre (BDC) in Biberach provides attractive spaces for more than 500 researchers.

Boehringer Ingelheim Biopharmaceutical Production

Boehringer Ingelheim is one of the leading biotech companies in Europe and has consolidated this position in the last th

Boehringer Ingelheim Biopharmaceuticals Project, Shanghai

German pharmaceutical company Boehringer Ingelheim is developing a biologics manufacturing facility at the Zhang Jiang Hi-tech Park in Shanghai.

Boehringer Ingelheim Biotechnology Process Plant, Biberach, Germany

In 2000, biotechnology company Boehringer Ingelheim awarded Stuttgart company Life Science Meissner & Wurst an engineering contract for the expansion of its Biberach plant.

Boehringer Ingelheim microParts Atomisation Factory

Boehringer Ingelheim microParts, a subsidiary of Boehringer Ingelheim Group, invested $94m in a new atomisation factory in Dortmund as part of its expansion strategy.

Boehringer Ingelheim Pharmaceutical R&D Building, Biberach, Germany

Boehringer Ingelheim is a Germany-based company with interests in pharmaceuticals, biopharmaceuticals, chemicals and ani

Boehringer Ingelheim Research Institute of Molecular Pathology (IMP)

The construction of a research facility for the Research Institute of Molecular Pathology (IMP) at the Vienna Biocentre in the third district of Vienna, Austria, fully sponsored by Boehringer Ingelheim, began in March 2015.

Boehringer Ingelheim’s New Tablet Production Facility, Ingelheim

Germany-based pharmaceutical company, Boehringer Ingelheim, is building a tablet production facility in Ingelheim, Germany, with an estimated investment of more than €85m ($97.2m).

Boehringer Ingelheim’s US Headquarters

Germany-based privately held pharmaceutical company Boehringer Ingelheim invested more than $350m in 2011 to boost its operations in the US.

Boehringer Ingelheim’s Biopharmaceutical Production Facility, Vienna, Austria

Boehringer Ingelheim’s large-scale cell culture production facility opened in October 2021.

Boehringer Ingelheim’s Integrated Asian Veterinary R&D Centre, Shanghai

Germany-based pharmaceutical company Boehringer Ingelheim’s veterinary research and development (R&D) centre is located within its research and development (R&D) site in Shanghai, China.

Boehringer Ingelheim’s Manufacturing Facility Expansion, Fremont, California

German pharmaceutical company Boehringer Ingelheim has broken ground on a $217m expansion of its facility in Fremont, California.

Boehringer’s Chemical Innovation Plant, Ingelheim, Germany

Boehringer Ingelheim will open a new chemical innovation plant (CIP) at its headquarters in Ingelheim, Germany, in 2026.

Brecon Pharmaceutical Manufacturing Expansion, Hay-On-Wye, Hereford

Brecon Pharmaceuticals Ltd, a subsidiary of AmerisourceBergen, is based in the Wye Valley Business Park near Hay-on-Wye

Brigham Translational Research and Clinical Facility, Boston

The construction of the Brigham translational research and clinical facility, also known as the Brigham Building for the Future (BBF), was initiated by the Brigham and Women’s Hospital (BWH) in June 2013.

Bristol Myers Squibb Biologics Manufacturing Facility, County Dublin

In November 2014, Bristol Myers Squibb (BMS), a global pharmaceutical company based in New York, announced plans to build a state-of-the-art biologics manufacturing facility in County Dublin, Ireland.

Bristol Myers Squibb East Syracuse Pharmaceutical Manufacturing Facility

The Bristol Myers Squibb East Syracuse campus is more than 60 years old. Launched in 1943, the pharmaceutical manufacturing facility made nearly 70% of the penicillin produced in the world until the mid-2000s.

Bristol Myers Squibb’s New CAR-T Cell Therapy Facility, Leiden, Netherlands

US-based pharmaceutical company Bristol Myers Squibb (BMS) is to build a new Chimeric Antigen Receptor T-cell (CAR-T) therapy manufacturing facility at the Leiden Bio Science Park in Leiden, Netherlands.

Bristol-Myers Squibb

In 2006, Bristol-Myers Squibb (BMS) announced a major investment of $220m (€176m) for the expansion of its biol

Bristol-Myers Squibb – Clinical Supplies Manufacturing

Bristol-Myers Squibb (BMS) has been undergoing much the same rationalisation process as many large pharmaceutical compan

Bristol-Myers Squibb Manufacturing Plant, Devens, Massachusetts

In June 2006, US-based pharmaceutical company Bristol-Myers Squibb pledged to build a large-scale multi-product biopharmaceutical manufacturing plant in Devens, Massachusetts.

Bristol-Myers Squibb’s Bulk Manufacturing Facility in Cruiserath, Ireland

In November 2000, Bristol-Myers Squibb began the construction of a new bulk manufacturing facility in the Republic of Ireland.

Bristol-Myers Squibb’s New Cell Therapy Manufacturing Facility, Devens, Massachusetts, US

Bristol-Myers Squibb (BMS), a global pharmaceutical company based in the US, is constructing a new cell therapy manufacturing facility in Devens, Massachusetts, US.

Buck Institute Regenerative Medicine Research Center, California

The New Regenerative Medicine Research Center in California was opened in April 2012. It focuses on how the regeneration of human cells can be used for treating fatal diseases.

Building Cure, Seattle Children’s Research Institute, Seattle

Seattle Children's Research Institute (SCRI) is building a paediatric research building, Building Cure, at Stewart Street in Seattle.

Bushu Pharmaceuticals’ Manufacturing Facility Expansion, Misato, Japan

Bushu Pharmaceuticals unveiled a new expansion programme for its pharmaceutical manufacturing facility in Misato, Japan, in August 2020.


C Wayne McIlwraith Translational Medicine Institute, Colorado State University

In June 2017, Colorado State University (CSU) started building the C Wayne McIlwraith Translational Medicine Institute (TMI).

Cambrex Corporation API Facility Expansion, Charles City, Iowa

In July 2016, US-based innovative life sciences company Cambrex Corporation completed a major expansion of its active pharmaceutical ingredient (API) facility in Charles City, Iowa.

Cambrex Profarmaco, Paullo

Cambrex Profarmaco, Cambrex's Milan facility, is a cGMP manufacturing facility located 25km southeast of Milan, Italy. T

Cambrex’s Biopharmaceutical Facility Expansion, Durham, North Carolina

Cambrex expanded its biopharmaceutical analysis capabilities at its Durham facility in North Carolina, US.

Cambridge Major Laboratories Active Pharmaceutical

Cambridge Major Laboratories constructed a large active pharmaceutical ingredients (API) production facility in Germanto

Cambridge Major Laboratories New Active Pharmaceutical Ingredient (API) Facility

Cambridge Major Laboratories (CML) opened a new active pharmaceutical ingredient (API) facility in July 2009. Located

Cancer and Cardiovascular Research Building, University of Minnesota

The Cancer and Cardiovascular Research Building at 23rd Avenue, south-east of Minneapolis, Minnesota, US, was officially opened in June 2013.

CanSino Ebola Vaccine Manufacturing Facility, Tianjin, China

In October 2015, Tianjin CanSino Biotechnology (CanSino) began building its first fully integrated Ebola vaccine manufacturing facility in the Tianjin Economic-Technological Development Area (TEDA) west zone in China.

Capella Biomedical Research Laboratory, Cambridge Biomedical Campus

In February 2016, the construction of a laboratory building known as Project Capella began at the Cambridge Biomedical Campus in Cambridge, UK.

Capsugel Spray-Dried Dispersion Facility, Bend City, Oregon

In June 2015, US-based pharmaceutical company Capsugel finished building a pharmaceutical spray-dried dispersion (SDD) commercial manufacturing facility at its existing research and development (R&D) facility in Bend City, Oregon.

CARsgen Therapeutics’ CAR T-Cell Therapy Manufacturing Facility, North Carolina

CARsgen Therapeutics opened its first US cGMP manufacturing facility in North Carolina for producing CAR-T-cell products.

Cascade Chemistry’s Manufacturing Facility Expansion, Eugene

Cascade Chemistry, an American pharmaceutical contract development and manufacturing organisation (CDMO), is constructing new facilities to expand the current good manufacturing practices (cGMP) pharmaceutical manufacturing capacity of its Eugene site in the US.

Catalent Biomanufacturing Center of Excellence, Madison, Wisconsin

Catalent Pharma Solutions opened a state-of-the-art bio-manufacturing centre of excellence in Madison, Wisconsin, US, in April 2013.

Catalent’s Biologics Drug Manufacturing Facility Expansion, Bloomington, USA

Catalent will invest around $350m to expand its biologic drug manufacturing facility in Bloomington, Indiana.

Catalent’s Biologics Manufacturing Facility Expansion, Anagni, Italy

Catalent is expanding its biologics manufacturing facility in Anagni, Italy, with a $100m investment.

Catalent’s Biologics Manufacturing Facility Expansion, Bloomington, Indiana, US

Catalent announced plans to expand its biologics manufacturing facility in Bloomington, Indiana, US

Catalent’s Covid-19 Vaccine Manufacturing Facility, Anagni

Catalent Biologics’ manufacturing facility in Anagni, Italy will serve as the launch facility for the large-scale production and supply of the University of Oxford’s Covid-19 vaccine candidate, AZD1222.

Catalent’s Plasmid DNA Manufacturing Facility, Gosselies, Belgium

Catalent has added a commercial-scale plasmid DNA (pDNA) manufacturing facility to its campus in Gosselies, Belgium.

Cellares’ IDMO Smart Factory, Bridgewater, New Jersey, US

Cellares will launch the world's first commercial-scale IDMO Smart Factory in Bridgewater, New Jersey, by 2024.

Cellectis’ Cellular Therapies Manufacturing Facility, Raleigh, North Carolina

Cellectis is building a new facility named Innovative Manufacturing Plant for Allogeneic Cellular Therapies (IMPACT) in Raleigh, North Carolina, US.

Cellipont Bioservices’ Cell Therapy Manufacturing Facility, Houston, Texas

Cellipont Bioservices’ new 76,000ft² manufacturing facility for cell therapies will be located in The Woodlands, Houston.

Celltrion biopharmaceutical plant, Incheon

Celltrion, a joint venture between San Francisco-based Vaxgen and a group of South Korean investors, completed the const

Centocor Biopharmaceutical

Centocor, a subsidiary of Johnson & Johnson, announced in July 2004 the investment of €500m in the constructio

Central Institute for Translational Cancer Research (TranslaTUM), Technical University of Munich

The Central Institute for Translational Cancer Research (TranslaTUM) is a new interdisciplinary research building at the Technical University of Munich (TUM).

Ceva New Poultry Vaccine Production Facility

Ceva Animal Health (Ceva), a wholly owned US subsidiary of Ceva Santé Animale and a leading player in the global animal

CGT Catapult Manufacturing Facility Expansion

The CGT Catapult Manufacturing Facility, a cell and gene therapy manufacturing facility, in Stevenage in Hertfordshire, UK was expanded in September 2019.

Chao Center for Industrial Pharmacy and Contract

The Chao Center for Industrial Pharmacy and Contract Manufacturing is based in Purdue Research Park, West Lafayette, Indiana and linked to the Purdue University department of Industrial and Physical Pharmacy and Pharmaceutical Sciences.

Charnwood Campus’ Building 42 Research Facility Modernisation, Loughborough, UK

The Charnwood Campus is a life sciences technology park located in Loughborough, UK, which accommodates global MedTech and biopharma companies to promote their business growth.

ChemSyn (Aptuit) Pharmaceutical Manufacturing Plant

ChemSyn Laboratories (now Aptuit), a leading producer of anti-cancer bulk pharmaceuticals and other high potency chemica

Chengdu Vaccine Plant

In early 2007 Technip was awarded a contract by the Chengdu Institute of Biological Products (CDIBP) for the design, con

Children’s Mercy Research Institute, Kansas City, US

Children’s Mercy is building a paediatric research institute at its Adele Hall Campus in Kansas City, Missouri.

China-Biotics, Probiotic Plant, Shanghai

China-Biotics is one of China's largest suppliers of probiotics. In 2009 it opened a bulk additive production facility i

Chugai Pharmaceutical Antibody API Manufacturing Plant, Tokyo, Japan

In October 2015, Japanese pharmaceutical company Chugai Pharmaceutical announced its decision to build a plant for manufacturing antibody active pharmaceutical ingredients (APIs) at its existing Ukima Plant in Kita-ku, Tokyo.

Chugai Pharmaceutical Bulk Antibody

Chugai Pharmaceutical opened the first phase of its antibody production facility in Utsunomiya, Japan, in early 2004, fo

Chugai Pharmaceutical’s New Synthetic Research Facility, Tokyo

Japanese pharmaceutical company Chugai Pharmaceutical is developing a synthetic research facility at its existing location in Kita-ku, Tokyo.

Cincinnati Children’s Hospital Medical Centre Clinical Sciences Building

The construction of a 15-storey clinical science building at Cincinnati Children's Hospital Medical Centre (CCHMC) began in June 2012.

Cipla Biosimilars Manufacturing Facility, Durban, South Africa

India-based pharmaceutical company Cipla has announced plans to build a manufacturing facility in Durban, KwaZulu-Natal, South Africa.

Cipla Medpro Pharmaceuticals, South Africa

Cipla Medpro Pharmaceuticals is listed on the Johannesburg Securities Exchange and is one of South Africa's top ten and

Civica’s Sterile Injectable Manufacturing Facility, Virginia

Civica is building a new manufacturing facility in Petersburg, Virginia for the uninterrupted production and supply of vials and syringes for essential injectable drugs.

Clariant Healthcare Packaging Plant, Cuddalore, Tamil Nadu

In January 2016, Switzerland-based speciality chemical company Clariant broke ground for its new manufacturing and healthcare packaging plant in Tamil Nadu, India.

Clinical and Translational Research Building, University of Florida

The University of Florida started construction of a new clinical and translation research building at its Mowry Road, Gainesville campus in Florida in May 2011.

Clinical and Translational Research Centre, New York

The clinical and translational research centre (CTRC) was inaugurated in September 2012. It is located in the University at Buffalo (UB) medical campus in Buffalo, New York.

Clover Biopharmaceuticals Biomanufacturing Facility, Changxing, China

Chinese biotechnology company Clover Biopharmaceuticals is planning to build a biomanufacturing facility in the Changxing Economic and Technological Development Zone (CETDZ) of Zhejiang, China.

CMC Biologics Seattle Facility Expansion

In August 2010 CMC Biologics completed the first stage of expansion at its site in Bothell near Seattle, Washington, U

Cobra Biologics Manufacturing Facility Expansion, Matfors

Cobra Biologics, a contract development and manufacturing organisation (CDMO), is expanding its manufacturing facility located in Matfors, Sundsvall, Sweden, with an estimated investment of €20m ($22.47m).

Cold Spring Harbour Laboratory Centre for Therapeutics Research, New York

In October 2017, Cold Spring Harbour Laboratory (CSHL) broke ground on its new Centre for Therapeutics Research (CTR) facility in New York.

Colorcon Film Coating Manufacturing Facility, Malaysia

Colorcon will build a new film coating manufacturing facility in Johor State, Malaysia, by July 2025.

Columbus Innovation District, Ohio State University

The Columbus Innovation District is a proposed healthcare and technology hub within the Ohio State University in the state of Ohio, US.

Cook Pharmica Biotechnology Plant

Cook Pharmica LLC, the newest Cook Group company, completed the construction of a $70m biotechnology facility in Blo

Coquí RadioPharmaceuticals’ Medical Isotope Production Facility, Florida

In April 2015, Puerto Rican pharmaceutical company Coquí RadioPharmaceuticals (Coquí) completed the schematic design for a medical isotope production (MIP) facility in Alachua County, Florida. Coquí has started work on the detailed design for the facility.

Cordis Corporation Manufacturing Plant, Cashel, Co Tipperary

Cordis Corporation was established in Miami in Florida, US in 1959. The company is a subsidiary of the pharmaceutical major Johnson & Johnson.

Core Technology Facility, University Of Manchester, Manchester

The new Core Technology Facility (CTF) has been opened on the Manchester University campus as a nursery for biotech star

CoreRX Tampa Facility Expansion

US formulation development company CoreRx Pharmaceuticals (CoreRx), initiated a major expansion of its manufacturing sit

CoreRx’s New Product Development Centre, Florida

CoreRx, a contract development and manufacturing organisation (CDMO) based in the US, unveiled a new facility in Clearwater, Florida, in April 2020.

Coriolis Pharma’s ATMP Facility, Martinsried, Germany

Coriolis Pharma opened its new ATMP development facility under biosafety level S2 (BSL2/S2) in February 2022.

Cortex Biotech Facility, Missouri

CORTEX, the Center of Research, Technology & Entrepreneurial Exchange, has constructed a new biotech complex to encourag

CPI Wet Granulation Manufacturing Facility, Durham, UK

In April 2019, Centre for Process Innovation (CPI) announced plans to develop a wet granulation manufacturing facility in Durham, UK.

Croda’s Lipid Systems Manufacturing Facility, Lamar, Pennsylvania, USA

Croda will build a lipid systems manufacturing facility with an investment of up to $133m in Lamar, Pennsylvania, by 2025.

CSL Recombinant Proteins Production Plant, Melbourne, Australia

The CSL Parkville facility has undergone several phases of expansion since 1997 when it was first opened. The production facilities have been expanded three times.

Cubist Pharmaceuticals Facility Expansion, Lexington

US based biopharmaceutical company Cubist Pharmaceuticals owns and operates a lab and research facility in Lexington,

CureVac GMP IV Production Facility, Tubingen, Germany

German pharmaceutical company CureVac is developing a good manufacturing practice (GMP) compliant ribonucleic acid (RNA) production facility at its headquarters in Tubingen, Germany.

Cytiva’s New Manufacturing Facility, Shrewsbury, Massachusetts, USA

Cytiva opened a new facility for manufacturing Xcellerex XDR bioreactors in Shrewsbury, Massachusetts, US, in December 2020.


Daiichi Asubio Pharma New Bio Plant (NBP), Gunma Prefecture

Daiichi Asubio Pharma, a subsidiary of the Daiichi Pharmaceutical Group, opened its New Bio Plant (NBP) at the start of

Daiichi Sankyo Company, Pharmaceutical Plant, Beijing, China

In June 2000, Daiichi Sankyo Company opened a new pharmaceutical plant in Beijing.

Dainippon Sumitomo Pharma’s Chemistry Research Building, Osaka

Dainippon Sumitomo Pharma (DSP) opened a new chemistry research building in Osaka, Japan, in June 2013.

Datwyler’s Elastomer Components Manufacturing Facility, Middletown, Delaware

In December 2016, Datwyler began constructing a new elastomer component manufacturing plant in Delaware, US.

Dendreon Biopharmaceutical Manufacturing Plant, Seattle

Dendreon is a US biotechnology company based in Seattle in the spotlight over its controversial cancer vaccine for the t

Dishman Carbogen Amcis API Facility, Bavla, Ahmedabad, India

Dishman Carbogen Amcis has commissioned its first high-containment API facility at its Bavla site in Ahmedabad, India.

Djavad Mowafaghian Centre for Brain Health, Vancouver

The Djavad Mowafaghian Centre for Brain Health located near the University of British Columbia (UBC) hospital along Wesbrook Mall on the UBC campus in Vancouver, Canada, was inaugurated in February 2014.

Dr Reddy’s Cuernavaca Manufacturing Facility

Dr Reddy's Laboratories launched a new manufacturing facility at its Cuernavaca site in Mexico on 17 March 2010. The fac

DSM Premix Vitamin Plant, Jalisco, Mexico

Hoffman La Roche built a vitamin premix plant in 2000 at El Salto in Jalisco, Mexico, to expand its operations in the premix vitamin market.

Dubai Biotechnology and Research Park (DuBiotech), Dubai, UAE

DuBiotech is the first free zone developed in the Middle East that is dedicated to the life sciences industry.

Duke Research and Discovery @RTP Campus, North Carolina

Duke Research and Discovery @RTP is a new research and discovery hub of the Duke University School of Medicine.


Eastman Chemical Company, Intermediates and Bulk Actives Facility, Arkansas, US

In 1999, Eastman Chemical Company began construction of a small-scale current good manufacturing practice (cGMP) facilit

Eirgenix Protein Drug Production Plant

Eirgenix, a Taiwanese contract development and manufacturing organisation (CDMO), opened a protein drug production plant in Zhubei, Taiwan, in January 2019.

Eisai Centre for Genetics Guided Dementia Discovery, Massachusetts, US

The Eisai Centre for Genetics Guided Dementia Discovery (G2D2) is being developed at the Alewife Research Centre in Cambridge, Massachusetts.

Eisai Knowledge Centre, Visakhapatnam

Eisai Knowledge Centre is located in the Special Economic Zone at the Jawaharlal Nehru Pharma City in Visakhapatnam, Andhra Pradesh, India.

Eisai Parenteral Facility North Carolina

Eisai Inc, a US subsidiary of Japan-based pharmaceutical company Eisai, opened a new parenteral facility in Research Tri

Eisai’s New Oral Solid Dose Production Facility, Suzhou

Eisai China has built a new oral solid dose (OSD) production facility at its new Suzhou plant in China.

Elan Pharma Secondary Pharmaceutical Facility

Elan Pharma is a biopharmaceutical company working in the development of drugs for the treatment of a wide range of ther

Eli Lilly Biotech Pilot Plant, Indianapolis

In October 2006 Eli Lilly completed the first phase of its biotech facility expansion in Indianapolis, which was made re

Eli Lilly Humalog Manufacturing Facility, Carolina

In April 2001 Eli Lilly announced it was constructing a new biotech bulk manufacturing facility in Carolina, Puerto Rico

Eli Lilly Kinsale Pharmaceutical Manufacturing Facility

Eli Lilly made a commitment to invest approximately $400m in a biologics manufacturing facility in December 2006.

Eli Lilly’s New Bio Manufacturing Plant, Cork

Eli Lilly announced the development of a new biomanufacturing plant in Ireland, in February 2012.

Eli Lilly’s Parenteral Product and Device Manufacturing Facility, Concord, North Carolina

Eli Lilly will invest more than $1bn in its second injectable product and device manufacturing facility in North Carolina, US.

Eli Lilly’s Pharmaceutical Manufacturing Facility, Durham, North Carolina

Eli Lilly is building a pharmaceutical manufacturing facility in Durham County, North Carolina, US.

EMD Sereno Research Facility, Massachusetts

EMD Serono, a wholly owned subsidiary of Merck KGaA, which is based in Darmstadt, Germany, launched a new research fac

Eminence GMP Cell Culture Media Manufacturing Facility, Suzhou, China

Eminence has opened a GMP manufacturing facility in Suzhou to meet the growing demand for cell culture media products.

Emulate’s New Headquarters and Laboratory, Boston, Massachusetts

US-based pharmaceutical company Emulate inaugurated a new headquarters and laboratory in Seaport District in Boston, Massachusetts, in February 2016.

Eskayef Bangladesh, Dhaka, Tongi

Eskayef Bangladesh, also known as Eskayef Pharmaceuticals or SK+F, is one of the largest and fastest expanding pharmaceutical companies located in Tongi, Bangladesh.

European Molecular Biology Laboratory Site, Barcelona

The European Molecular Biology Laboratory (EMBL) is developing a facility within the Barcelona Biomedical Research Park (PRBB) campus in Spain.

Evergreen Theragnostics’ Radiopharmaceutical Manufacturing Facility, New Jersey

Evergreen Theragnostics, a radiopharmaceutical contract development and manufacturing organisation (CDMO) based in New Jersey, US, is developing a state-of-the-art radiopharmaceutical manufacturing facility in New Jersey, US.

Evonik’s New Biomaterials Manufacturing Facility, Birmingham, Alabama

German speciality chemicals company Evonik has launched a new advanced biomaterial manufacturing facility in Birmingham, Alabama, US, in May 2020.

Evonik’s Lipid Production Facility, Lafayette, Indiana, USA

Evonik will build a lipid production facility at its Tippecanoe site in Lafayette, Indiana, with a $220m investment in 2023.

Evonik’s Pharmaceutical Lipids Manufacturing Facility, Hanau, Germany

Evonik opened a clinical and small-scale commercial pharmaceutical lipids manufacturing facility in Hanau, Germany.

ExoCoBio’s Exosome GMP Manufacturing Facility, Osong, South Korea

ExoCoBio is building the world’s first clinical-grade exosome good manufacturing practice (EGMP) facility in South Korea.

Experic’s Manufacturing and Packaging Facility, New Jersey, USA

Experic plans to build a pharmaceutical research, manufacturing and packaging facility in Cranbury, New Jersey.

Experimental Sciences Building II, Texas Tech University (TTU)

In February 2017, Texas Tech University (TTU), alongside TTU System, started building the Experimental Sciences Building II (ESB-II) at its campus in Lubbock, Texas.


Fermion API Manufacturing Facility Expansion, Hanko

Finland-based pharmaceutical company Fermion is expanding its facility in Hanko, Finland, to increase its manufacturing and commercial production capabilities.

Ferring Pharmaceuticals

Ferring Pharmaceuticals announced its intention in 2003 to build a new production site at Saint-Prex, Canton of Vaud in

Ferring Pharmaceuticals Biotechnology Centre, Saint-Prex, Switzerland

In February 2018, Swiss biopharmaceutical company Ferring Pharmaceuticals announced plans to build a biotechnology centre at its headquarters in Saint-Prex, Switzerland.

Ferring Pharmaceuticals Freeze Drying

Ferring Pharmaceuticals of Kiel, Wittland, Germany – a subsidiary of Ferring BV of Switzerland – began const

Fiocruz’s Vaccine Manufacturing Centre, Manguinhos, Brazil

In 2001, Brazilian Government institute Fiocruz Instituto de Tecnologia em Imunobiologicos completed one of the largest vaccine manufacturing centres in Latin America.

Forest City Enterprises’ Pharmaceutical Facility in Skokie, Illinois, US

Now owned by Pfizer, Pharmacia Corporation announced in 2000 the opening of its new facility in Skokie in Illinois, US.

Fraunhofer Plant-Based Vaccine Factory

Fraunhofer CMB opened a new cGMP plant-based vaccine facility in Newark, Delaware, in April 2010. The facility is a

Fresenius Kabi’s Pharmaceutical Manufacturing Facility Expansion, Melrose Park, Illinois

In August 2016, German pharmaceutical company Fresenius Kabi announced plans for an expansion of the pharmaceutical manufacturing capabilities of its site in Melrose Park, Illinois.

Fresenius Kabi’s Pharmaceutical Manufacturing Facility Expansion, Wilson, North Carolina

German pharmaceutical firm Fresenius Kabi is expanding its pharmaceutical manufacturing facility in Wilson, North Carolina.

Fujifilm Diosynth Biotechnologies Flexible Biomanufacturing Facility, Texas

Fujifilm Diosynth Biotechnologies (FDB) embarked on an expansion of its flexible biomanufacturing facility at its College Station location in Texas, US, in February 2020.

Fujifilm Diosynth Biotechnologies New Biocampus, Billingham

Fujifilm Diosynth Biotechnologies (FDB) is building a Biocampus at its Billingham, UK site.

Fujifilm Diosynth Biotechnologies’ Advanced Therapies Innovation Centre, College Station, Texas

Fujifilm Diosynth Biotechnologies (FDB) began the construction of its Advanced Therapies Innovation Centre in College Station, Texas, US.

Fujifilm Diosynth Biotechnologies’ Biologics Production Facility Expansion, Hillerod, Denmark

Fujifilm will expand its large-scale biologics production facility in Hillerod to transform it into Europe’s largest end-to-end CDMO.

Fujifilm Diosynth Biotechnologies’ Biomanufacturing Facility Expansion

Fujifilm Diosynth Biotechnologies is expanding its existing BioProcess Innovation Center in North Carolina, US.

Fujifilm Diosynth Biotechnologies’ Cell Culture Manufacturing Facility, North Carolina

Fujifilm Diosynth Biotechnologies (FDB), a subsidiary of Japanese conglomerate Fujifilm, is building a new cell culture manufacturing facility in Holly Springs, North Carolina, US.

Fujifilm’s Cell Culture Media Manufacturing Facility, Netherlands

Fujifilm opened a new cell culture media production facility in Tilburg, the Netherlands, in December 2021.

Fulton Labs, Chicago

Fulton Labs is a new laboratory facility being developed in Chicago, Illinois, US, the first life science laboratory space in Chicago's Fulton Market.

Fusion’s Radiopharmaceutical Manufacturing Facility, Ontario, Canada

Fusion opened a radiopharmaceutical facility to produce targeted alpha therapies (TATs) for cancer in Hamilton, Ontario, Canada.


GE Healthcare Biopharmaceutical Campus, Cork County, Ireland

Multinational healthcare service provider GE Healthcare has announced plans to invest $170m to develop a biopharmaceutical campus in Cork County, Ireland.

GE Healthcare Biotechnology Manufacturing Centre, Stevenage, UK

In November 2018, GE Healthcare opened a new manufacturing centre in Stevenage, UK. The facility is scheduled to open for commercial operations in the first half of 2019.

GE Healthcare Pharmaceutical Manufacturing Plant, Shanghai, China

In 2000, Nycomed Amersham announced it would open a new pharmaceutical plant in Shanghai on 27 October.

GE Healthcare Viral Vector Manufacturing Facility, Worcester

GE Healthcare (GEHC) Life Sciences and the University of Massachusetts Medical School (UMMS) unveiled plans to set up a manufacturing facility for gene therapy in Worcester, US, in December 2019.

GE Healthcare’s Manufacturing Facility, Grens

GE Healthcare is building a manufacturing facility for cell processing kits in Grens, Switzerland.

GE Healthcare’s API Facility Expansion, Lindesnes, Norway

GE Healthcare will expand its facility in Lindesnes to increase contrast media production by 30 million doses a year by 2025.

GEA Niro Pharmaceutical Spray Drying Facility, Copenhagen

GEA Niro's GMP pharmaceutical spray drying facility is part of the company's Test Centre located in Copenhagen, Denmark.

Gedeon Richter Biopharmaceutical Plant, Debrecen, Hungary

In July 2008, Gedeon Richter, one of Hungary's largest pharmaceutical companies, started building a facility for the development and manufacture of biopharmaceutical products in Debrecen.

Gemini Bio’s New Manufacturing Facility, West Sacramento

Cell culture solutions provider Gemini Bioproducts (Gemini Bio) opened its new manufacturing facility in West Sacramento, California, US, in June 2020.

Genentech Cell Culture Plant No 2 Expansion

Genentech is one of the most successful biotech companies on a world scale with four drugs prominent on the commercial m

Genentech Inc Fill and Finish Facility

Genentech is one of the leading biotechnology corporations in the US, with facilities around the world and more than 10,

Genentech Manufacturing Facility (NIMO)

The NIMO (New Idec Manufacturing Operation) in Oceanside, San Diego, was originally built by Idec as the company wanted

Genentech Singapore Biologics Plant

Lonza Biologics Singapore has built a large-scale cell culture manufacturing facility in Singapore's Tuas Biomedical Par

Genentech’s Biologics Manufacturing Facility, Oceanside, California, USA

Genentech’s first-of-its-kind commercial biologics manufacturing facility in Oceanside will be operational in 2025.

GenScript’s Biologics Manufacturing Centre, Zhenjiang

GenScript Biotech is constructing a biologics manufacturing centre in Zhenjiang city, Jiangsu Province, China.

Genzyme Biomanufacturing Plant

In June 2007, Genzyme Corporation announced the construction of a new biomanufacturing plant in Lyon, France. The compan

Genzyme Flanders NV, Biopharmaceutical Plant Expansion, Geel

Genzyme Flanders is a European subsidiary of the US biotech giant Genzyme Corporation. The 70,000ft² facility in Ge

Genzyme Manufacturing Expansion

Genzyme Corporation is one of most prominent biotechnology companies in the US. Based in Cambridge, Massachusetts, it wa

Genzyme Manufacturing Expansion, Waterford

Genzyme Corporation is one of the world's leading biotech manufacturers and announced the establishment of a manufacturi

Genzyme R&D Facility

Genzyme, the third largest biotechnology company in the world by sales, is constructing a new research and development

Genzyme Science Center Framingham, Massachusetts, USA

Genzyme Corporation is one of the world's leading biotechnology companies, which has been in operation since 1981. G

Gibbs Cancer Centre and Research Institute, Pelham, South Carolina

Gibbs Cancer Centre and Research Institute began building a $65m facility in Pelham, North Carolina, with an official ground-breaking ceremony held on 17 May 2016.

Glaxo Wellcome Anti-Infective Drugs Plant, Suzhou, China

In 1998, Glaxo Wellcome made an investment in a production facility in Suzhou in the eastern Chinese province of Jiangsu.

GlaxoSmithKline Antibiotic Plant Expansion, Irvine, Scotland

GlaxoSmithKline (GSK) opened its expanded antibiotics facility in Irvine, Scotland, in February 2016.

GlaxoSmithKline Manufacturing and Packaging Plant, Zebulon, NC

In 1999, UK-based pharmaceuticals company Glaxo Wellcome instigated a project to expand its 652,000ft² manufacturing and packaging plant in Zebulon, NC.

GlaxoSmithKline Manufacturing Facility Expansion, Boronia

GlaxoSmithKline (GSK) announced the expansion of its manufacturing facility in Boronia, in the outer eastern suburbs of Melbourne, Australia, in November 2014.

GlaxoSmithKline Vaccine Manufacturing Facility, Tuas

GlaxoSmithKline (GSK) has had a presence in Singapore since the 1970s with its investment in an antibiotics plant. Since

GlaxoSmithKline’s (GSK) Pharmaceutical Tablet Manufacturing Factory, Karnataka

GlaxoSmithKline (GSK) began construction of an oral solid-dose manufacturing plant at the Vemgal Industrial Area in India in September 2015.

Glycotope Biotechnology Antibody Production Facility

Glycotope Biotechnology, a wholly owned subsidiary of Glycotope GmbH, operates an antibody production facility in Heid

Grail’s RTP Cancer Test Manufacturing Facility, North Carolina

US-based healthcare company Grail is building a state-of-the-art laboratory facility in the Research Triangle Park (RTP), North Carolina. The facility will primarily function as a commercial cancer lab for sample processing.

GRAM’s Pharmaceutical Manufacturing Facility, Michigan, US

Opened in June 2020, GRAM’s third injectable fill/finish facility tripled its existing footprint in Grand Rapids, Michigan.

Green Cross Biotherapeutics’ Biomanufacturing Facility, Montreal

In June 2015, biopharmaceutical company Green Cross Biotherapeutics (GCBT) broke ground on the construction of Canada’s first intravenous immunoglobulin (IVIG) and albumin manufacturing plant in Montreal, Quebec.

Grifols’ North Fractionation Facility (NFF), Clayton

North Fractionation facility (NFF), a new plasma fractionation plant, was inaugurated by Grifols in June 2014 at Clayton in North Carolina, US.

Grindeks Final Dosage Forms Facility, Riga

Grindeks is one of the leading pharmaceutical companies in the Baltic States and its main areas of activity are heart an

Grindeks Ursodeoxycholic Acid Manufacturing Plant

Latvia-based Grindeks opened a new active pharmaceutical ingredient (API) manufacturing unit in Riga in June 2011.

Gritgen Therapeutics’ GMP Gene Therapy Facility, Suzhou, China

Gritgen Therapeutics opened a GMP gene therapy facility in Suzhou, China, to produce gene therapy product for haemophilia A.

GSK Biologicals Manufacturing Plant

The vaccine manufacturing plant of GlaxoSmithKline (GSK) in Dresden, Germany mainly produces the company's seasonal infl

GSk Vaccine Manufcaturing Plant, St Amand Les Eaux

GSK Biologicals, the vaccine division of the pharmaceutical and healthcare company GlaxoSmithKline (GSK), announced its

GSK’s New Biopharmaceutical Plant, Ulverston

GlaxoSmithKline (GSK) unveiled plans for the construction of a new biopharmaceutical plant in the UK in February 2014.

Gulf Pharmaceutical Industries (Julphar) Insulin Production Facility

Gulf Pharmaceutical Industries, known popularly as Julphar, is set to inaugurate the first ever insulin production facility in the Middle East.

GVK Biosciences’ Clinical Pharmacology Unit

GVK Biosciences, a contract research organisation based in the city of Hyderabad, India, operates a clinical pharmaco


H3 Biomedicine New Research Facility

H3 Biomedicine, the American subsidiary of Tokyo-based company Eisai, opened its new research facility in Cambridge, in the state of Massachusetts, US, in December 2011.

HALIX cGMP Biopharmaceutical Facility, Leiden

HALIX inaugurated its new current good manufacturing practice (cGMP) biopharmaceutical manufacturing facility at the Leiden Bioscience Park, Netherlands, in November 2019.

Halo Pharmaceuticals Whippany Facility

Halo Pharmaceuticals' Whippany facility is a cGMP compliant pharmaceutical manufacturing and packaging plant. The faci

Hameln Pharma Sterile Facility

Contract manufacturer hameln pharma's sterile production facility at Hameln, Germany was built to enhance the production

Hanmi Pharmaceutical Bio Manufacturing Plant, Pyeongtaek

Korea-based pharmaceutical company Hanmi Pharmaceutical is building a biologics manufacturing facility in Pyeongtaek in the Gyeonggi province of South Korea.

Haupt Pharma, New Packaging Line

Haupt Pharma is one of the world's largest contract manufacturers of pharmaceuticals. With nine production sites across

Health Sciences Biomedical Research Facility, UCSD, California

In March 2014, the University of California, San Diego (UCSD), opened a health sciences biomedical research facility in La Jolla, California.

Helsinn New Cytotoxic Plant, Biasca

Switzerland-based pharmaceutical ingredient manufacturer Helsinn expanded its Biasca site in Switzerland with a new cytotoxic API manufacturing facility.

Hermes Pharma Production Plant, Wolfsberg, Austria

Hermes Pharma GmbH has developed and produced compounds at its Wolfsberg plant in Austria since 2003. The company also h

Hitachi Chemical’s Cell and Gene Therapy Manufacturing Facility, New Jersey

Hitachi Chemical Advanced Therapeutics Solutions (HCATS) opened its new manufacturing facility in New Jersey, US, in January 2020, developed to meet the demand for cell and gene therapy manufacturing services.

Hoffman La Roche Biotechnology Plant Expansion, Penzberg, Upper Bavaria

Hoffman La Roche, the Swiss biotech company, began expanding its biotech production capacity in 2004 with the constructi

Hovione API Facility Expansion, East Windsor, New Jersey

Portugal-based pharmaceutical company Hovione is expanding its active pharmaceutical ingredient (API) facility in East Windsor, New Jersey.

Hovione Manufacturing Plant, Loughbeg, County Cork

The production plant at Loughbeg in County Cork, Ireland, is currently owned by Hovione.

Hovione’s Continuous Manufacturing Facility, Loures, Portugal

Hovione has expanded its continuous tableting capacity with a state-of-the-art manufacturing facility at its site in Loures, Portugal.

Hovione’s Pharmaceutical Manufacturing Facility Expansion, East Windsor, New Jersey

Hovione's New Jersey pharmaceutical campus will have additional commercial spray drying manufacturing capacity added by 2023.

Huntsman Cancer Institute Expansion, Utah

The Huntsman Cancer Institute (HCI) is a part of the University of Utah campus in Salt Lake City, Utah.


IC Asia Pharmaceutical Plant

IC AsiaCo Ltd (Indochina Co Ltd), a subsidiary of Indochina Pharmaceutical Co., Ltd, began construction on the Dong103bn

IDT Biologika Live Human Viral Vaccine Production Facility

IDT Biologika is one of the leading biotechnology companies in Germany with its origins in the Bacteriological Institute

IDT’s Therapeutic Oligonucleotide Manufacturing Facility, Iowa, US

IDT’s therapeutic oligonucleotide manufacturing facility produces cell and gene therapy reagents.

IDT’s New Manufacturing Facility, North Carolina

Integrated DNA Technologies (IDT) opened a manufacturing facility in North Carolina's Research Triangle Park in the US in May 2020 for supporting research and testing efforts related to the Covid-19 pandemic.

ILC Dover Manufacturing Facility

In May 2019, ILC Dover opened a manufacturing facility in Ireland to produce the company’s pharmaceutical and biopharmaceutical product lines. The plant is designed to strengthen the company's single-use powder handling solutions business.

Imaging Centre of Excellence, University of Glasgow, Scotland

In March 2017, the Imaging Centre of Excellence (ICE) at the Queen Elizabeth University Hospital (QEUH) in Scotland was inaugurated.

ImClone Systems Biopharmaceutical Plant, New Jersey, US

In January 2000, ImClone Systems began construction of a new 100,000ft² biopharmaceutical manufacturing facility in Branchburg, New Jersey.

Indena Anti-Cancer Compound Plant Automation

Indena SpA, an Italian company based in Settala near Milan, has announced plans to automate its plant for the production

Inhalable Insulin Manufacturing Facility, Frankfurt, Germany

In early November 1998, Hoechst Marion Roussel (HMR) and Pfizer announced their intention to jointly develop, produce and sell inhalable insulin on a global scale.

International Stem Cell Corporation Stem Cell Manufacturing Facility

The International Stem Cell Corporation (ISCO) launched its new Oceanside stem cell manufacturing facility in February

InterVac, University of Saskatchewan

In September 2011, the University of Saskatchewan opened a new vaccine research and development (R&D) centre at its campus in Saskatoon, Canada.

Iovance Biotherapeutics Cell Therapy Production Facility

In May 2019, Iovance Biotherapeutics announced its plans to build a cell therapy production facility in Philadelphia, US.

Iroko Pharmaceuticals Global Headquarters, Philadelphia

Iroko Pharmaceuticals inaugurated its new global corporate headquarters in December 2012 at Navy Yard Corporate Centre in Philadelphia, USA.

Isis Pharmaceuticals New R&D Facility, California

Isis Pharmaceuticals inaugurated a new research and development (R&D) facility at Carlsbad in California, USA in September 2011. The new facility is provided with sophisticated drug discovery and development facilities.


James L. Sorenson Molecular Biotechnology Building, Utah

University of Utah's new innovation centre, the James L. Sorenson Molecular Biotechnology Building, was officially dedicated in April 2012.

Janssen Pharmaceutica’s Pharmaceutical Plant, Geel, Belgium

Johnson & Johnson (J&J) subsidiary Janssen Pharmaceutica decided to build a new pharmaceutical plant in Geel in Belgium in 1998.

Janssen Sciences’ Biomedicines Manufacturing Facility, Ringaskiddy, Ireland

Janssen Sciences Ireland has expanded its biomedicines manufacturing facility in Barnahely, Ringaskiddy in County Cork, Ireland, with the addition of the BioCork II manufacturing building.

Jazz Pharmaceuticals Development and Manufacturing Facility, Athlone

Ireland-based biopharmaceutical company Jazz Pharmaceuticals has opened a manufacturing facility in Athlone, Ireland.

JC Wilt Infectious Diseases Research Centre, Winnipeg

The Public Health Agency of Canada (PHAC) opened a new infectious diseases research centre at 745 Logan Avenue in the Winnipeg city of Manitoba province, Canada, in February 2014.

Jennie Smoly Caruthers Biotechnology Building, Colorado

University of Colorado's Jennie Smoly Caruthers Biotechnology Building (JSCBB) was opened in April 2012. It has been built with an investment of $160m.

JHL Biotech Biosimilars Manufacturing Facility, Wuhan, China

In May 2016, Taiwan-based biopharmaceutical company JHL Biotech officially inaugurated a single-use bioprocessing technology-based KUBio™ modular biopharmaceutical manufacturing facility in Wuhan, China.

JHP Pharmaceuticals Manufacturing Facility

JHP Pharmaceuticals, a maker of sterile injectable products, owns and operates a manufacturing site in Rochester, Mi

Jill and John Freidenrich Center for Translational Research (FCTR), Stanford University

The Jill and John Freidenrich Center for Translational Research was officially opened in October 2012.

Jinyu Bio-technology Research Facility, Kansas

In May 2017, Chinese animal vaccine company Jinyu Bio-technology unveiled plans to establish its first US-based vaccine research lab and office facility, located in Kansas.

John and Editha Kapoor Hall, University at Buffalo, US

John and Editha Kapoor Hall is located on the south campus of the University at Buffalo in New York, United States. It houses the School of Pharmacy and Pharmaceutical Sciences.

John Edward Porter Neuroscience Research Center, Maryland

The John Edward Porter Neuroscience Research Centre in Bethesda, Maryland, was opened and dedicated to the public in March 2014.

Jubilant HollisterStier’s Sterile Injectable Manufacturing Facility Expansion, Spokane, US

US-based contract pharmaceutical manufacturer Jubilant HollisterStier is expanding the sterile injectable production capacity at its facility in Spokane, Washington.

Julphar Manufacturing Facility, Addis Ababa

UAE-based pharmaceutical firm Gulf Pharmaceutical Industries (Julphar) officially opened a new pharmaceuticals manufacturing facility in February 2013.

Juno Therapeutics Headquarters and R&D Facility, Washington

In September 2017, Juno Therapeutics has inaugurated a research and development (R&D) facility in Seattle, Washington, with a $232m investment.


KBI Biopharma, North Carolina Center For Biomanufacturing, Durham, North Carolina

KBI BioPharma, a division of Atlanta-based Kinetic Biosystems Inc, decided in late 2003 that the home of its new contrac

KBI Biopharma’s Biologics Manufacturing Facility, North Carolina, USA

KBI Biopharma has opened a 150,000ft² biologics manufacturing facility in Durham, North Carolina.

Kemwell Biopharmaceutical Manufacturing Facility, Bangalore

Kemwell is building a new biopharmaceutical manufacturing facility in Bangalore, India. The green-field site will be c

Kemwell Pharmaceutical Manufacturing Facility

India-based contract manufacturer Kemwell launched a new solid and semi-solid pharmaceutical manufacturing facility in

Kilitch Drugs Manufacturing Plant

Indian pharmaceuticals manufacturing company Kilitch Drugs produces and markets drug formulations in solid, liquid and parenteral dosage forms.

Kindeva’s Aseptic Fill-Finish Manufacturing Facility, Bridgeton, Missouri, US

Kindeva will expand its capabilities in Bridgeton, Missouri, with a new aseptic fill-finish manufacturing facility by 2024.

Kite Pharma’s CAR T-cell Therapy Production Facility, Maryland

In April 2019, Kite Pharma announced plans to develop a new chimeric antigen receptor (CAR) T-cell therapy production facility in Maryland, US.

Kite Pharma’s Biopharmaceutical Manufacturing Facility

Kite Pharma, a subsidiary of Gilead Sciences, announced about the construction of its new biopharmaceutical manufacturing facility in Hoofddorp, the Netherlands.

Kite Pharma’s Viral Vector Manufacturing Facility, California, US

Kite Pharma received US FDA approval for its viral vector manufacturing facility in Oceanside in October 2022.

Knight Cancer Institute Research Building, Oregon

Oregon Health and Science University’s (OHSU) Knight Cancer Institute has built a research building at South Waterfront district in south-west Portland, Oregon.

Kondirolli Pharmaceutical Facility, Pristina

When the war in Kosovo ended in June 1999 the country, including its capital Pristina, was in a terrible state. Out of a


Krka, a Slovenian pharmaceutical company, opened a new solid dosage forms production facility in Istra, northwest Moscow

Krka Notol Pharmaceutical Plant

Krka is a major pharmaceutical and chemical products supplier based in Novo Mesto in Southern Slovenia on the Krka River

KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban

KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) is located in Durban, South Africa. K-RITH was founded in 2008 by the Howard Hughes Medical Institute (HHMI) and the University of KwaZulu-Natal (UKZN).


LabCentral 238, Cambridge, Massachusetts, USA

LabCentral 238 in Cambridge, Massachusetts, will be fully opened in 2022 after the completion of its second phase.

Lakes BioScience’s New Biomanufacturing Plant, Ulverston

Lakes BioScience is planning to build a pharmaceutical manufacturing plant in Ulverston, Cumbria, UK. The new facility will be built as part of the company’s Project Apex, an initiative to create a customer-focused contract development and manufacturing organisation (CDMO).

Leaf Systems Bioscience Research Facility, Norfolk

Leaf Systems International has opened a bioscience research and development (R&D) facility at the Norwich Research Park in Norfolk, UK.

LG Chemical Pharmaceutical Plant, Iksan, South Korea

The LG Chemical Pharmaceutical Plant is owned by Lucky Goldstar Chemical (LG Chemical), a sub-division of one of South Korea's best-known chaebols (business groups).

Liberation Labs’ Precision Fermentation Biomanufacturing Facility, Indiana, US

The company is expected to invest approximately $115m for the development of the facility.

Lilly Institute for Genetic Medicine, Boston, Massachusetts, USA

The Lilly Institute for Genetic Medicine, being developed by Eli Lilly, will focus on developing RNA-based therapies.

Lonza Biologics Facility, Guangzhou, China

Lonza and GE Healthcare are developing a biologics facility in Guangzhou, China.

Lonza Biologics Plant Expansion

Lonza Biologics completed the large-scale expansion of their facility in Portsmouth, New Hampshire, Pease International

Lonza Biotec

Lonza Biotec completed the construction of new manufacturing capacity with a multi-product design at Visp in Switzerland

Lonza cGMP Manufacturing Facility, Slough

Lonza operates a cGMP manufacturing facility in Slough, UK. Located close to Heathrow Airport in London in the Thames Va

Lonza Houston’s Biotech Facility, Pearland, Texas

In April 2018, viral and cell therapy manufacturer Lonza Houston finished building a biotech facility for immunotherapy development and manufacturing in Pearland, Texas.

Lonza Niacinamide Production Facility, Iksan, South Korea

Lonza Fine Chemicals and Specialties put a production facility for niacinamide into operation in 1997 following a joint venture (JV) agreement with the Guangzhou Pesticide Factory.

Lonza’s Ibex Biomanufacturing Complex, Visp, Switzerland

Lonza has developed a new biomanufacturing complex at its biopark in Visp, Switzerland.

Lonza’s Bioconjugation Facility Expansion, Visp

Lonza completed the expansion of its bioconjugation facility at its Visp site in Switzerland in February 2023.

Lotus Pharmaceuticals Facility

China-based prescription drug developer and pharmaceutical manufacturer Lotus Pharmaceuticals is constructing a new he

Louis A Simpson and Kimberly K Querrey Biomedical Research Centre, Northwestern University

Construction of the Louis A Simpson and Kimberly K Querrey Biomedical Research Centre at Northwestern University Feinberg School of Medicine in Chicago, Illinois, began in May 2015.

Louisiana Cancer Research Centre, New Orleans

The construction of the Louisiana Cancer Research Center was initiated in April 2009 and completed by 2012.

Lowy Cancer Research Institute

The Lowy Cancer Research Institute, located in the premises of University of New South Wales (UNSW), Sydney, is the largest cancer research centre in southern Australia.

LS Skaggs Pharmacy Institute, University of Utah, Salt Lake City

The LS Skaggs Pharmacy Institute is a research facility opened in April 2013 for the College of Pharmacy at the University of Utah in Salt Lake City, Utah.

Lykan Bioscience’s SMART Manufacturing Facility, Hopkinton, Massachusetts

Lykan Bioscience opened a purpose-built SMART Manufacturing™ facility for developing cell-based therapies in Hopkinton, Massachusetts, US, in September 2020.


MaaT Pharma’s Microbiome Ecosystem Therapies Manufacturing Facility, France

MaaT Pharma has built Europe’s largest cGMP facility with Skyepharma to produce microbiome ecosystem therapy.

MannKind’s Afrezza Manufacturing Facility, California

MannKind Corporation is a bio-pharmaceutical firm located in the city of Santa Clarita, California, in the US.

Mapi Pharma’s Sterile Injectable Production Plant in Jerusalem

Israel-based clinical-stage pharmaceutical company Mapi Pharma has announced the development of a new sterile injectable production plant in Jerusalem.

Marine Biological Laboratory’s Loeb Lab Renovation

Marine Biological Laboratory (MBL) is an internationally recognised not-for-profit research, education and training institute for environmental, biomedical and biological sciences.

Masy Systems Biorepository

The importance of custom cell lines and biological samples for use in biotechnology manufacturing is increasing. To keep

Max Planck Florida Institute (MPFI), Jupiter, Florida

Germany-based Max Planck Society opened its new biomedical research facility, the Max Planck Florida Institute (MPFI), in June 2012.

Mayne Pharma’s Oral Solid Dose Manufacturing Facility, Greenville, North Carolina

Australian pharmaceutical company Mayne Pharma has opened an oral solid dose (OSD) commercial manufacturing facility in Greenville, North Carolina.

Medicago cGMP Vaccine Facility

Canada-based pharmaceutical company Medicago broke ground for the construction of a new influenza vaccine production pla

Medicago’s Vaccine Production Facility, Quebec, Canada

Medicago is constructing a new influenza vaccine production facility in the Estimauville Innovation Area in Quebec City, Canada.

Medical and Research Translation (MART) Building, Stony Brook University

Construction of the Medical and Research Translation (MART) building at the Stony Brook University (SBU) medical centre campus began in November 2013.

Medicines Manufacturing Innovation Centre, Renfrewshire, Scotland

The Centre for Process Innovation (CPI) is building the Medicines Manufacturing Innovation Centre in Renfrewshire, Scotland.

Medimmune, Biologics Manufacturing Facility

In September 2006 MedImmune, a Maryland-based biologics company working in the areas of infectious diseases, cancer and

Medis International Drug Packaging Plant

Medis International opened a new drug packaging plant in Bolatice, Czech Republic, in December 2009. Construction was co

Medlac Pharmaceutical Plant

Medlac is an Italy-based pharmaceutical company specialising in dermatological products. The company officially inaugurated a new 10,000m² manufacturing plant in Vietnam in April 2011.

Meissner Filtration Products’ Manufacturing Facility, Castlebar, Ireland

Meissner Filtration Products is developing a new manufacturing facility in County Mayo, Castlebar, Ireland.

Merck And Co Vaccine Facility, Carlow, Ireland

Merck Sharpe and Dohme, the world's seventh largest pharmaceutical company, has a highly successful vaccine division

Merck Biotech Development Facility, Corsier-sur-Vevey, Switzerland

Merck’s new biotech development facility in Corsier-sur-Vevey, Switzerland, is expected to begin full-scale operations by 2023.

Merck Frosst Centre for Therapeutic Research

Merck Frosst's Kirkland facility is the oldest and the largest biomedical research facility in Canada. Established in

Merck Innovation Center, Darmstadt

Merck KGaA’s innovation centre at its global headquarters in Darmstadt was built as a part of a €1bn ($1.12bn) strategic initiative.

Merck Pharmaceutical Manufacturing Facility Expansion, Molsheim, France

Merck will expand its manufacturing capabilities in Molsheim, France, with an investment of more than €130m ($129.1m).

Merck Serono Biopharmaceutical R&D Facility Expansion, Darmstadt

In September 2015, Merck Serono began an expansion of its research and development (R&D) facility within the new Pharma Square on its campus in Darmstadt, Germany.

Merck Serono’s Pharmaceutical Manufacturing Facility, Nantong, China

The Nantong facility is one of Merck's largest pharmaceutical manufacturing plants in the world.

Merck Sharpe & Dohme Formulation Plant

Merck Sharpe & Dohme, known as MSD Technology Singapore Pte Ltd in Singapore, opened their newest manufacturing facility

Merck Vaccine Plant, Durham, NC, USA

Merck's 272,000ft² vaccine production plant is located on a 262-acre site in Treyburn Corporate Park on the north s

Merck’s Pharmaceutical Packaging Facility, Hangzhou

Merck officially inaugurated a new drug packaging facility at Hangzhou in April 2013. The new plant is located in the Hangzhou Economic and Technology Area (HEDA) in Hangzhou.

Merck’s Reagent Manufacturing Facility, Nantong, China

The plant will be developed on the NETDA site, one of China's first national-level economic and technological development zones.

Merck’s Biodevelopment Centre Expansion, Martillac, France

Merck has expanded its site in Martillac, France, by adding a commercial facility for manufacturing drug substances.

Merck’s Biotech Manufacturing Facility Expansion, Aubonne, Switzerland

In March 2019, Merck announced plans to expand its biotech manufacturing facility in Aubonne, Switzerland.

Merck’s Cell Culture Media Production Facility Expansion, Kansas, USA

Merck expanded its cell culture media production facility in Lenexa, Kansas, with an investment of €23m ($25m).

Meridian Life Science Biopharmaceutical Facility

Meridian Life Science is a premier manufacturer of critical reagents for the in-vitro diagnostic industry and a contrac

Merrion Biopharma Research and Development Laboratories

Merrion's new R&D facility located in Citywest, south Dublin, Ireland is a state-of-the-art facility designed to accommo

Metrics’ Oral Solid-Dose Commercial Facility Expansion, North Carolina

Metrics added 3,760ft² of manufacturing space and equipment to its oral solid-dose commercial facility in July 2021.

Michael J Fox Foundation for Parkinson’s Disease Research, New York, US

The Michael J Fox Foundation for Parkinson's Research aims to encourage the development of therapies to treat Parkinson's disease.

Michael Uren Biomedical Engineering Research Hub, London

The Michael Uren Biomedical Engineering Research Hub is a state-of-the-art laboratory and office facility being developed at the Imperial College London campus in White City, London.

Michigan State University Bioengineering Facility, East Lansing, Michigan

Michigan State University (MSU) has opened a bioengineering facility at its campus in East Lansing, Michigan.

MilliporeSigma Life Science Campus, Burlington, Massachusetts

In October 2017, MilliporeSigma, the life sciences division of Germany-based science and technology firm Merck, opened a life science campus in Burlington, Massachusetts.

MilliporeSigma’s ADC Manufacturing Facility Expansion, Madison, Wisconsin, USA

MilliporeSigma opened a 70,000ft² facility with a $69m investment to double its HPAPI production capacity in Madison, US.

MilliporeSigma’s M Lab Collaboration Center, Shanghai

MilliporeSigma opened its new M LabTM Collaboration Center in Shanghai in July 2020, the company’s largest such centre to date.

Minakem’s High-Containment Production Facility, Louvain-la-Neuve, Belgium

In the second half of 2018, Minakem opened a new high-containment production facility in Louvain-la-Neuve, Belgium.

Moderna mRNA Vaccine Manufacturing Facility, Quebec, Canada

Moderna’s new mRNA vaccine manufacturing facility in Quebec is intended to strengthen Canada’s readiness to deal with pandemics.

Moderna Science Centre, Cambridge, Massachusetts

Moderna’s science centre will serve as its new headquarters and support the company’s future research and discoveries.

Moderna Therapeutics Clinical Manufacturing Facility, Massachusetts, USA

Moderna opened a GMP clinical manufacturing facility in Norwood, Massachusetts, in July 2018 with a $110m investment.

Moderna’s mRNA Vaccine Manufacturing Facility, UK

Moderna’s state-of-the-art mRNA Innovation and Technology Centre will produce up to 250 million vaccine doses a year.

Morphotek’s New Biologics Production Facility

Morphotek, a subsidiary of Eisai Co, opened a pilot manufacturing plant for the production of antibodies for early phase clinical trials of biologics in Welsh Road, Exton, Pennsylvania, US, in August 2012.

MSD Biologics Advanced Biologics Centre

Avecia Biotechnology announced a $100m investment in a new advanced centre for biologics manufacture in Billingham,

MSD’s Manufacturing Plant Expansion, Ballydine Co Tipperary, Ireland

Between 1997 and 1999, Merck Sharp and Dohme (MSD) undertook a two-year expansion of its manufacturing facility in Ballydine Co Tipperary, Ireland.

MSD’s Biologics Manufacturing Facility, Swords, Ireland

In February 2018, US-based pharmaceutical company Merck Sharp and Dohme (MSD) announced its plans to develop a biologics manufacturing facility in Dublin, Ireland.

MSU Grand Rapids Research Centre, Michigan, USA

The Grand Rapids Research Centre at Michigan State University was opened in September 2017.

Mubadala’s Biopharma Manufacturing Facility, Abu Dhabi, UAE

Mubadala will build the first GMP biopharma manufacturing facility in Abu Dhabi to boost the UAE's life sciences ecosystem.


NanoViricides cGMP Production Plant, Shelton, Connecticut

In August 2013, NanoViricides began building a clinical-scale current good manufacturing practice (cGMP) production plant at the industrial-commercial zone on the Route 8 Corridor in Shelton City, Connecticut.

NantWorks Pharmaceutical Manufacturing Plant, Indiana

NantWorks, a US-based pharmaceutical company, announced it was to setup a new drug manufacturing plant in Vigo County, in the state of Indiana, in January 2012.

National Biologics Manufacturing Centre, Darlington

Construction of the National Biologics Manufacturing Centre at Central Park in Darlington, UK, began in April 2014.

National Biomanufacturing Centre

The National Biomanufacturing Centre (NBC) is a biotech plant constructed on a 60,000ft² plot on the Estuary Commer

Navesta Pharmaceuticals’ Sterile Pharmaceutical Manufacturing Plant, Horana

In August 2017, Sri Lanka-based pharmaceutical company Navesta Pharmaceuticals opened a sterile manufacturing facility in the town of Horana.

Neopharma Pharmaceutical Plant, Abu Dhabi, UAE

Neopharma’s pharmaceutical plant in Abu Dhabi produces 300 types of drugs and medicines under various brands.

Neuroscience Building, University of Miami

The University of Miami began construction of a new neuroscience facility at the Coral Gables campus in April 2012.

Neurosciences Research Building, Indiana University, Indianapolis

Construction of a new neurosciences research building at Indiana University (IU) in Indianapolis, US, was initiated in August 2012.

New Orleans BioInnovation Center

New Orleans BioInnovation Center (NOBIC) is located on Canal Street in New Orleans, US. It was opened in June 2011 and officially inaugurated in September 2011.

NextPharma Clinical Trial Services Facility, Gottingen

NextPharma's Clinical Trial Services (CTS) facility in Gottingen, Germany, launched in December 2008. The facility is an

NextPharma San Diego Facility

NextPharma's San Diego facility in California, USA, is a cGMP contract manufacturing facility serving companies in the b

NextPharma SVA Facility

UK-based contract manufacturer NextPharma's plant in Braine-l'Alleud, Belgium specialises in the production and packagin

Nexus Pharmaceuticals’ Sterile Injectable Manufacturing Facility, Pleasant Prairie, USA

Nexus’ sterile injectable manufacturing facility in Wisconsin will be fully developed with a $250m investment in ten years.

Nippon Shinyaku Corporation, Pharmaceuticals Formulation Production Plant, Odawara, Japan

The Nippon Shinyaku Corporation's pharmaceuticals formulation production plant Odawara, Japan, began construction in January 2000 and was completed in February 2001.

NJ Biopharmaceuticals’ Manufacturing Facility and Headquarters, Princeton, New Jersey

NJ Biopharmaceuticals will open a facility in Princeton to provide GMP manufacturing capabilities to clients for antibody drug conjugates.

Northeast Texas Cancer and Research Institute, Tyler, Texas

The Northeast Texas Cancer and Research Institute is being built within the CHRISTUS Trinity Mother Frances hospital complex in Tyler.

Norwich Pharmaceuticals Norwich Facility

A leading provider of contract manufacturing and packaging services, Norwich Pharmaceuticals has served the pharmaceutic

Nova Southeastern University (NSU) Centre for Collaborative Research

Nova Southeastern University (NSU) has opened the Centre for Collaborative Research (CCR) on its main campus in Davie, Florida.

NovaMedica Pharmaceutical Plant, Kaluga

In May 2017, Russian pharmaceutical company NovaMedica began building a pharmaceutical manufacturing plant for sterile injectable drugs at the Vorsino Industrial Park, Kaluga, Russia.

Novartis Biomanufacturing Plant

Novartis is a multinational pharmaceutical company, based in Basel in Switzerland. The company has plants situated acros

Novartis Biotechnology Centre Expansion, Huningue

Swiss pharmaceutical company Novartis is carrying out a major expansion of its biotechnology centre in Huningue, France.

Novartis Diovan Manufacturing Plant, Schweizerhalle, Switzerland

In September 1999 Novartis opened a new pharmaceutical production facility at the Schweizerhalle site near Basel, Switzerland.

Novartis Institute of BioMedical Research

The Novartis Institute of BioMedical Research (CNBIR) is located in the Zhangjiang High-Tech Park in the Pudong New Area

Novartis Pharmaceutical Development Centre

On 2 November 2009, Novartis officially opened its new global technical centre Suzhou Novartis Pharma Technology Co in R

Novartis Pharmaceutical Manufacturing Plant, St Petersburg, Russia

In June 2011, Swiss pharmaceutical company Novartis began building a pharmaceutical manufacturing facility in St Petersburg, Russia.

Novartis Stein Cell and Gene Therapy Facility

Novartis opened its new cell and gene therapy facility in Stein, Switzerland, in November 2019. The site is intended to support the production of innovative medicines.

Novartis Vaccine Manufacturing Facility

Novartis has begun production at its new vaccine manufacturing facility in Marburg, Germany in April 2011. The plant produces rabies and tick-borne encephalitis (TBE) vaccines.

Novartis Vaccine Manufacturing Facility, North Carolina

In July 2006 Novartis announced that it would build a new vaccine manufacturing facility in Holly Springs, North Carolina, US.

Novartis’ API Plant in Grimsby, West Yorkshire, UK

Novartis Pharmaceuticals' active pharmaceutical ingredients (API) plant complex in Grimsby, West Yorkshire, was first established in 1951.

Novavax and CPL Biologicals Influenza Vaccine Manufacturing Facility

Novavax, in association with CPL Biologicals, completed the construction of its new influenza vaccine manufacturing faci

Novavax Covid-19 Vaccine Manufacturing Facility

Novavax’s new vaccine manufacturing facility located in Bohumil, Czech Republic will develop and manufacture the company’s vaccine candidate for Covid-19, NVX‑CoV2373.

Novavax Vaccine Plant

Novavax is a biotechnology company developing a novel process to create vaccines against a wide range of infectious dise

Novo Nordisk

Novo Nordisk decided in the spring of 2003 to market the long-acting insulin analogue Levemir (Insulin Detemir) first in

Novo Nordisk Insulin Cartridge, Chartres, France

Novo Nordisk is upgrading the insulin production plant at its facility in Chartres, Eure-et-Loir region, France. The Dan

Novo Nordisk Insulin Formulation and Filling Facility, Kaluga, Russia

In April 2015, Danish pharmaceutical company Novo Nordisk inaugurated an insulin formulation and filling facility at Grabtsevo Industrial Park in the Kaluga region of Russia.

Novo Nordisk Manufacturing Facility

Novo Nordisk's insulin manufacturing facility in North Carolina is located south-east of Raleigh near the town of Cla

Novo Nordisk Plant Expansion Tianjin

Novo Nordisk has had research and production facilities in China since 1994 when the company set up Novo Nordisk (Tianji

Novo Nordisk’s API Manufacturing Facility, Kalundborg, Denmark

Novo Nordisk will build a new API manufacturing facility to expand its existing facilities in Kalundborg.

Novo Nordisk’s Type I Diabetes Research Facility, Seattle

The largest city in the north-western United States, Seattle, has become a hub for pharmaceutical research activity with the world's leading pharmaceutical companies establishing their research and development (R&D) centres there.

Novo Nordisk’s Diabetes Active Pharmaceutical Ingredients (DAPI) Production Facility, Clayton

Danish pharmaceutical company Novo Nordisk broke ground on its diabetes active pharmaceutical ingredients (DAPIs) production facility in Clayton, North Carolina, in March 2016.

Novoseven Facility, Hillerød

The NovoSeven pharmaceutical facility in Hillerød, Denmark was constructed by NNE (Novo Nordisk Engineering), the e

Novozymes Innovation Campus, Copenhagen

Denmark-based biotechnology company Novozymes is building an innovation campus in Copenhagen.

Nuclea Genomics Center

Nuclea Biotechnologies, a translational medicine and genomics firm, launched a new genomics centre, on 4 August 2010.

NuSil Technology’s Clean Room Manufacturing Facility

NuSil Technology opened a new clean room manufacturing facility on 14 April 2010. Located in Carpinteria, California, c


Organogenesis Cell Manufacturing Plant, Massachusetts

US-based regenerative medicine maker Organogenesis broke ground on the world's largest automated living cell manufacturi

Oxford Pharmaceuticals Generic Drug Facility, Birmingham, Alabama

In September 2015, US-based pharmaceutical start-up Oxford Pharmaceuticals broke ground on the construction of a generic drug manufacturing and distribution facility in Jefferson County, Birmingham, Alabama.


Parker Bioscience’s Manufacturing Facility Expansion, Birtley

Parker Bioscience Filtration, a subsidiary of US-based motion and control systems provider Parker Hannifin, has expanded the manufacturing capacity of its facility in Birtley, UK.

Parsolex’s CGMP Manufacturing Facility Expansion, West Lafayette, Indiana

Parsolex, a contract development and manufacturing organisation based in the US, partnered with Bosch Packaging Technology to equip its West Lafayette facility with the latest pharmaceutical packaging technologies, in November 2019.

Patheon Manufacturing Facility Expansion, Toronto

Canadian contract drug maker Patheon, completed the expansion of its Toronto manufacturing facility in April 2009, two m

Patheon Milton Park Facility

Patheon is one of the largest contract drug development and manufacturing service providers in the world. To meet the in

PBL’s Pharmaceutical Fermentation Facility, Wiltshire

In April 2018, Porton Biopharma Limited (PBL) opened a pharmaceutical fermentation facility at the Porton Down Science Park near Salisbury, Wiltshire, UK.

PCI’s Manufacturing Site Expansion, Bedford, New Hampshire, USA

PCI Pharma Services is building a 50,000ft² manufacturing facility at its Bedford campus to expand its portfolio.

PDL Bioharma Biotech Manufacturing

Protein Design Labs (renamed PDL Biopharma in 2005) announced plans to build a new manufacturing facility on a 29-acre s

Penang Biotech Park, Bukit Minyak, Malaysia

Penang Biotech Park is situated in the Bukit Minyak region of Malaysia in Penang (north-western coast of Peninsular Mala

Penn Pharmaceutical Tredegar Plant

Penn Pharmaceutical's Tredegar plant is located in the Tafarnaubach Industrial Estate in Gwent, South Wales, UK. Laun

Perkin Elmer Centre of Excellence, Singapore

According to a United Nation's report, Asia's population is expected to increase from 3.7 to 5.3 billion by 2050. With r

Pfizer Biologics Clinical Manufacturing Facility, Massachusetts

US-based pharmaceutical company Pfizer began building a biologics clinical manufacturing facility at its existing manufacturing facility in Andover, Massachusetts, in June 2016. The new facility will be used for producing high-quality, complex biologics and vaccines and is expected to come online by January 2019.

Pfizer Biotech Manufacturing Facility, Shanbally

In mid-2007 it was reported that Pfizer, one of the largest pharmaceutical companies present in the Republic of Ireland,

Pfizer European R&D Headquarters, Sandwich, Kent

Pfizer's Sandwich site is the company's European R&D headquarters and global manufacturing hub. Located in south-east Ke

Pfizer Genotropin Manufacturing, Strangnas

Pfizer is one of the largest pharmaceutical companies in the world. Recent restructuring has led to the company putting

Pfizer Global Biotechnology Centre, Hangzhou, China

US-based pharmaceutical company Pfizer broke ground for the development of a Global Biotechnology Centre in China's Hangzhou Economic Development Area (HEDA) in June 2016.

Pfizer New Manufacturing Facility, Dalian

On 27 February 2009 Pfizer opened a new manufacturing facility at its Dalian site in Liaoning Province, northeast China.

Pfizer R&D Facility

Pfizer's New London facility is a world-class research and development (R&D) centre located in the State of Connecticu

Pfizer R&D Facility, Chesterfield, Missouri

In June 2017, US-based biopharmaceutical company Pfizer began building a research and development (R&D) laboratory and office facility in Chesterfield, Missouri.

Pfizer’s Biotechnology Campus, Clondalkin, Ireland

Pfizer will invest €1.2bn ($1.26bn) to expand its Biotechnology Campus in Grange Castle by 2027.

Pfizer’s Bulk Pharmaceuticals Facility, Tuas, Singapore

The large-scale pharmaceutical facility in Tuas, Singapore, is Pfizer's first manufacturing facility in the country.

Pfizer’s Synthesis Facility, Ringaskiddy, Ireland

Pfizer will create additional manufacturing and laboratory spaces at its existing manufacturing sites in Ringaskiddy.

Pfizer, Newcon Containment Facility, Germany

Pfizer Manufacturing Deutschland GmbH is a large secondary manufacturing centre for Pfizer in Germany and has a reputati

Pfizer’s Gene Therapy Manufacturing Facility Expansion, North Carolina

Pfizer, a pharmaceutical company based in the US, is expanding its gene therapy manufacturing facility located at Sanford campus in North Carolina, US.

Pfizer’s Sterile Injectable Production Facility, Michigan

In June 2018, Pfizer announced plans to build a sterile injectables production facility at Portage in Kalamazoo County, Michigan.

Pharmacia Parenterals Plant, Uppsala, Sweden

Pharmacia's parenterals plant is located in Uppsala in Sweden and was originally ordered by a Swedish pharmaceuticals company called Pharmacia & Upjohn.

Pharmalucence New Production Facility

Massachusetts-based radiopharmaceutical product supplier, Pharmalucence, is constructing a new pharmaceutical manufactur

Pharmaniaga Small Volume Injectables (SVI) Facility

Pharmaniaga LifeScience's small volume injectables (SVI) facility in Puchong, in the Selangor district of Malaysia, commenced commercial production in January 2011.

Pharmatek Laboratories cGMP Facility

Pharmatek Laboratories operates a cGMP manufacturing facility in San Diego. The custom designed facility offers a rang

Pharmavite Vitamin and Supplement Manufacturing Facility, Alabama

Pharmavite officially opened a new dietary supplement manufacturing facility in the US in June 2013.

Pharmavite’s Vitamin and Supplement Manufacturing Facility, Ohio, USA

Pharmavite will build its fourth facility in New Albany, Ohio, to increase its dietary supplement manufacturing capacity by 2024.

Pharmstar Pharmaceuticals Plant, Rocky Mount, North Carolina

PharmStar Pharmaceuticals Inc is a relatively new drug manufacturer, which is headquartered in Rocky Mount, North Caroli

Phebra Manufacturing Facility, Sydney

Phebra officially opened a new pharmaceuticals manufacturing facility at Lane Cove West in Sydney, Australia, in March 2013.

Phillips-Medisize Pharmaceutical Manufacturing Facility, Wisconsin

Phillips-Medisize is constructing a pharmaceutical manufacturing facility in Hudson, Wisconsin, US.

Phillips-Medisize’s Manufacturing Facility Expansion, Struer

Phillips-Medisize is expanding its existing global innovation and development (GID) centre in Struer, Denmark.

Phoenix Biomedical Campus Innovation Centre, Arizona

The Phoenix Biomedical Campus (PBC) Innovation Centre is a new 225,000ft² research facility situated within the larger Phoenix Biomedical Campus in Phoenix, Arizona, US.

Phoenix Chemicals Manufacturing Facility

The Annan facility, situated on a 154-acre site in Dumfriesshire, is currently part of Phoenix Chemicals. It has three i

Piramal Pharma Solutions’ API Manufacturing Facility Expansion, Riverview, Michigan

Piramal Pharma Solutions (PPS) is expanding its manufacturing facility in Riverview, Michigan, with an investment of approximately $32m to develop and manufacture potent and non-potent active pharmaceutical ingredients (API).

Piramal Pharma Solutions’ Ahmedabad PDS Facility Expansion, India

Ahmedabad PDS facility expansion will enhance Piramal Pharma Solutions’ existing in-vitro biology capabilities.

Piramal Pharma Solutions’ Manufacturing Facility Expansion, Aurora, Canada

Piramal Pharma Solutions completed an expansion of its manufacturing facility in Aurora to produce APIs in May 2022.

Piramal’s ADC Manufacturing Facility Expansion, Grangemouth, Scotland

Piramal is expanding its manufacturing facility located in Grangemouth, Scotland, to increase its ADC production capabilities.

Plough Centre for Sterile Drug Delivery Systems, Memphis

Construction of a drug manufacturing facility for the University of Tennessee Health Science Centre in Memphis, Tennessee, is expected to begin in September 2015.

POINT Biopharma’s New Manufacturing Facility, Indiana

POINT Biopharma, a clinical-stage biopharmaceutical company, is planning to construct its first US manufacturing plant in Indianapoli, Indiana.

Polpharma Dry Forms II Production Facility, Starogard Gdanski, Poland

Polpharma began production at its Dry Forms II plant in Starogard Gdanski, Poland, in February 2001.

Prestige BioPharma’s Innovative Discovery Centre, Busan, South Korea

Prestige BioPharma will open the Innovative Discovery Centre, its first global-scale R&D centre, in Busan by 2023.

Prestige Biopharma’s Vaccine Production Centre, Osong, South Korea

Prestige BioPharma opened a global-scale vaccine manufacturing centre in Osong, South Korea, in December 2021.

Process Control Update at Cedarburg’s Intermediate and API Facility, Grafton, US

Cedarburg Pharmaceuticals awarded Emerson Process Management with a contract in 1998 to supply the company with process controls for its new facility in Grafton, Wisconsin, US.

Progenitor Cell Therapy (PCT) Manufacturing Facility, Allendale, New Jersey

Progenitor Cell Therapy (PCT) launched phase one of a new cell development and manufacturing facility on 26 January 2010

Prolor Biotech R&D Facility, Weizmann Science Park

Prolor Biotech, a clinical phase biopharmaceutical company formerly known as Modigene, has opened a new corporate headq

Promega Corporation’s Manufacturing Facility, Wisconsin

Promega Corporation began construction of a regulated product manufacturing facility at Feynman Centre in the city of Fitchburg, Wisconsin, US, in August 2011.

Promega’s Kornberg Research and Development Centre, Fitchburg, USA

In April 2021, US-based biotechnology company Promega opened the Kornberg Centre, a research and development (R&D) facility located in Fitchburg, Wisconsin.

Pronova Biopharma Pharmaceutical Production Facility

Pronova BioPharma is one of the leading companies in the research and development of marine-originated omega-3 fatty aci

Protchem Industries Derivatives Plant, Chennai, India

In 1999, construction began on a derivatives plant for Protchem Industries.

pSivida Biosilicon Manufacturing Plant

pSivida is an Australian nanotech company specialising in the commercialisation of biodegradable nanotech silicon device

PTC Therapeutics’ Gene Therapy Manufacturing Centre of Excellence, Hopewell, New Jersey

PTC Therapeutics’ biologics facility will be located within the Bristol-Myers Squibb (BMS) campus in Hopewell, New Jersey.

Public Health England’s (PHE) New Campus in Harlow, Essex

Public Health England (PHE) is developing a public health science campus and headquarters in Harlow, Essex, UK.


Quality Chemical Industries – HIV Drug Plant

HIV, AIDS and malaria are massive problems throughout Africa. The drugs to treat and prevent these diseases are readily

Quay Pharma Deeside Facility, Wales

Quay Pharma, a UK-based pharmaceutical outsourcing company, is relocating operations from its current facility in Brombo

Quintiles Drug Research Unit

Quintiles, a US-based biopharmaceutical services company, inaugurated its new research facility in London on 8 March 2

QuVa Pharma’s Pharmaceutical Manufacturing Facility Expansion, New Jersey

QuVa Pharma is expanding its biotech pharmaceutical manufacturing facility in Bloomsbury, New Jersey, US as part of its multi-year growth spree to extend its pharmaceutical facilities beyond Texas.


Regenxbio’s Research and Development Facility, Maryland

Regenxbio is building a research and development (R&D) facility in Montgomery County in Rockville, Maryland, US.

Regis Technologies’ API Development Laboratories Expansion, Morton Grove, Illinois

Regis Technologies, a US-based contract development and manufacturing organisation (CDMO), completed the expansion of its custom active pharmaceutical ingredients (APIs) development laboratory facilities in Morton Grove, Illinois, in February 2021.

ReiThera Viral Vector Production Facility Expansion, Italy

ReiThera opened its expanded large-scale viral vector production facility in Italy in November 2022.

Rentschler Biopharmaceutical Manufacturing Facility Expansion

Rentschler Biopharma is carrying out an expansion of its recently acquired biopharmaceutical manufacturing facility located in Milford, US. The project is part of the company’s plan to expand its business in the US and Europe.

Rentschler Biotechnologie, New Manufacturing Capacity

Rentschler Biotechnologie GmbH is a full-service contract manufacturer and part of the Rentschler Group based in Lauphei

Research Institute of the McGill University Health Centre (RI-MUHC), Montreal

The McGill University Health Centre (MUHC) and its Research Institute (RI-MUHC) inaugurated a jointly built research institute at MUHC's Glen site in Montreal, Canada, in February 2015.

Richter Gedeon Hormone Production Facility

Richter Gedeon Vegyeszeti Gyar Rt, a well-known Hungarian pharmaceutical company, opened a new hormone production facili

Richter-Helm BioLogics Plant

Richter-Helm owns a biologics plant at Hanover Medical Park, Germany. The plant has been operational since 1987. It was

Robert and Beverly Lewis Integrative Science Building, University of Oregon

University of Oregon’s (UO) new Robert and Beverly Lewis Integrative Science Building (LISB) was opened in November 2012.

Roche Biotechnology Plant, Basel

Roche's biotechnology plant in Basel opened in May 2007. The plant was developed on the existing Roche production site,

Roche Bulk Active Ingredient Manufacturing Facility, Florence, SC

Roche Carolina is the highly successful US subsidiary of pharmaceutical giant Hoffmann La Roche. Roche has operated a pr

Roche Diagnostics PCR Diagnostic Kits

Roche Diagnostics completed the construction and commissioning of a new manufacturing facility in Branchburg, New Jersey

Roche New Research and Development Facility

Roche's new R&D facility is located in Wettsteinallee near Basel, Switzerland. It was officially inaugurated in November 2011. Roche made an investment of $271m in the site.

Roche Pharmaceutical Manufacturing Plant

Roche Mustahzarlari has completed the construction of their pharmaceutical facility at Gebze, close to Istanbul, Turkey.

Roche Vitamin Plant, Taishan, Shanghai

Roche's latest vitamin plant is located in Taishan, Shanghai, which is in the northeastern part of the Peoples' Republic of China.

Roche Vitamins and Minerals Premix Plant, Republic of South Africa

Hoffman La Roche completed the first phase of construction for a vitamins and minerals premix plant at Isando, Republic of South Africa, in June 2002.

Roche’s Basel Site Expansion, Basel

Roche, the world's fourth biggest pharmaceutical company of 2014, announced its investment plans on a major infrastructure development project at its Basel site in Switzerland in October 2014.

Rocket Pharmaceuticals’ Research and Development (R&D) and Manufacturing Facility, Cranbury

Rocket Pharmaceuticals will build a new research and development (R&D) and manufacturing facility in Cranbury, New Jersey, US to support the production of its pipeline of lentivirus and adeno-associated virus (AAV) gene therapies.

Rohner Custom Synthesis Plant

In March 1999 Rohner AG began the construction of a new state-of-the-art pharmaceutical facility at its existing site at

Romark’s New Manufacturing Facility, Manati

Romark has built a new manufacturing facility in Manati, Puerto Rico, for the production of its diarrhoea drug, Alinia® (nitazoxanide), for the US market.

Rosalind Franklin Biotechnology Centre, Delft, Netherlands

Netherlands-based healthcare company Royal DSM has opened a new facility, the Rosalind Franklin Biotechnology Centre, at its campus in Delft.

Rosalind Franklin University’s (RFU) Innovation and Research Park, Chicago

Rosalind Franklin University (RFU) has announced plans for the construction of an innovation and research park at the university's North Chicago campus.

Roxane Laboratories Oral Solid Dosage Facility

Roxane Laboratories has upgraded its 500,000ft² west-side pharmaceutical manufacturing plant in Columbus, Ohio, to

Rubius Therapeutics’ Pharma Manufacturing Facility, Rhode Island, US

Rubius Therapeutics is constructing a pharmaceutical manufacturing facility in Smithfield, Rhode Island, US.

Rusan Pharma’s API Manufacturing Facility, Madhya Pradesh, India

Rusan Pharma’s new state-of-the-art API manufacturing facility is located in Madhya Pradesh, India.

Rutgers University Chemistry and Chemical Biology Building, New Jersey

Construction of a new Chemistry and Chemical Biology (CCB) building began in June 2014 at the Rutgers University's Busch campus in New Jersey, US.


SAFC Dry Powder Media Manufacturing Plant, Irvine, Scotland

SAFC, a business unit of Sigma-Aldrich Corporation, opened a dry powder media (DPM) plant at its manufacturing facility in Irvine, Scotland, in January 2015.

SAFC Manufacturing Fermentation Facility

SAFC operates a contract manufacturing fermentation facility in Jerusalem, Israel. The facility is EU and FDA complian

SAFC Pharma API Manufacturing Expansion, Republic of Ireland

SAFC Pharma is a multinational operation, part of the US fine chemical company Sigma-Aldrich. SAFC specialises in provid

SAFC Pharma St Louis Facility, Missouri

SAFC Pharma's St Louis facility is a cGMP biologics manufacturing facility, which undertakes plant and animal-based ther

SAFC Verona HPAPI Manufacturing Facility

SAFC, a business division of Sigma-Aldrich, is a custom manufacturer and services provider for pharmaceutical and biopharmaceutical companies.

Sai Life Sciences’ New Research and Technology (R&T) Centre, Hyderabad

Contract development and manufacturing organisation (CDMO) Sai Life Sciences inaugurated its new research and technology (R&T) centre in Hyderabad, India in August 2020.

Sai Life Sciences’ Process Chemistry R&D Laboratory Expansion, Manchester

Sai Life Sciences announced the expansion of its process chemistry R&D laboratory at Alderley Park, Manchester, UK in January 2021.

SAJAPHCO JV’s Pharmaceuticals Formulation Plant, Saudi Arabia

In 1998, construction began on a new pharmaceuticals formulation plant in Jeddah, on the Red Sea coast of Saudi Arabia.

Salubrent Pharma Solutions Analytical Lab, Kannapolis, North Carolina

Salubrent’s analytical lab in Kannapolis, North Carolina, was built to help the company meet its long-term growth plans.

Samsung Biologics Bio Campus II, Incheon, South Korea

Samsung Biologics is building a second biopharmaceutical campus in the Songdo Industrial Cluster in Incheon, South Korea.

Samsung Biologics Manufacturing Plant, Incheon, South Korea

South Korea-based company Samsung Biologics broke ground on its first manufacturing plant in the free economic zone in Songdo, Incheon, in May 2011.

Samsung BioLogics’ Biological Manufacturing Facility, Songdo, South Korea

In October 2018, Samsung BioLogics opened its third biologics manufacturing plant in Songdo, South Korea. The plant made Samsung Group one of the world’s largest biologics contract manufacturing operators (CMOs).

Samsung Biologics’ P4 Super Plant, Songdo

Samsung Biologics is planning to expand its manufacturing facilities with the construction of its fourth biopharmaceutical manufacturing plant, P4-Super Plant, in Songdo, South Korea.

Sandoz Biosimilar Technical Development Centre, Slovenia

The project will require an estimated investment of $90m and will generate approximately 200 new jobs in Slovenia.

Sandoz Cefalosporin-Antibiotics Production Plant, Frankfurt, Germany

Biochemie (now Sandoz) has invested DM85 million ($41 million) in a new Frankfurt production plant which will become the

Sanford Consortium for Regenerative Medicine’s Stem Cell Research Facility

The Sanford Consortium for Regenerative Medicine (SCRM) inaugurated a new stem cell research facility in La Jolla in the state of California, US, in November 2011.

Sanofi Biologics Plant Expansion, Geel, Belgium

France-based pharmaceutical company Sanofi is expanding its biologics plant in Geel, Belgium, to add to its manufacturing and commercial production capabilities.

Sanofi Lantus SoloSTAR Pen Assembly Plant, Yizhuang, Beijing

Sanofi China opened a new assembling and packaging facility for prefilled insulin devices in Beijing, China, in May 2012. The facility will produce the SoloSTAR insulin injection pens.

Sanofi Manufacturing Plant, Goa, India

French pharmaceutical company Sanofi’s manufacturing facility in Goa, India, is located in the Verna Industrial Park, owned by Sanofi’s Indian arm Sanofi India, previously known as Aventis Pharma.

Sanofi Pasteur R&D Centre

Sanofi Pasteur, the vaccine division of Sanofi, opened a new vaccine research and development centre in Toronto, Ontar

Sanofi Pasteur Vaccine Plant, Val De Reuil, France

Sanofi Pasteur, the vaccines division of Sanofi Aventis, is focusing on a continuing technology upgrade and expansion. T

Sanofi Pasteur Vaccine Production Plant, Swiftwater, Pennsylvania

Sanofi Pasteur, the vaccines business of Sanofi-Aventis, is one of the largest seasonal influenza vaccine producers in t

Sanofi-Lonza Biologics Production Facility, Visp, Switzerland

Switzerland-based biopharmaceuticals supplier Lonza and French life sciences firm Sanofi have established a joint venture (JV) to set up a large-scale biologics production facility in Visp, Switzerland.

Sanofi’s Digital Manufacturing Facility, Massachusetts

Sanofi, a biopharmaceutical company based in France, opened a digital biopharmaceutical manufacturing facility in Framingham, Massachusetts, US, in October 2019.

Sanofi’s Evolutive Vaccine Facility (EVF), Neuville-sur-Saône

Sanofi is planning to build a new Evolutive vaccine facility (EVF) for the manufacturing of vaccines in Neuville-sur-Saône in the eastern part of France.

Sanofi’s Evolutive Vaccine Facility, Singapore

Sanofi will build its first-in-Asia, fully digitalised vaccine manufacturing facility in Singapore by 2025.

Sanofi’s Vaccine Manufacturing Facility, Toronto, Canada

French pharmaceutical company Sanofi Pasteur has unveiled plans to build a vaccine manufacturing facility in Toronto, Canada.

Sartorius Cell Culture Technology Centre, Germany

German biopharmaceutical and life sciences company Sartorius Stedim Cellca is developing a cell culture technology centre.

Sartorius’ Biopharmaceutical Manufacturing Facility Expansion, Puerto Rico

Sartorius has expanded its biopharmaceutical manufacturing facility Sartorius Stedim Campus, which is located in Yauco, Puerto Rico, US.

Saudi Vaccine and Biomanufacturing Centre

Saudi Vaccine and Biomanufacturing Centre is a research facility being constructed at the KAUST Research and Technology Park in Saudi Arabia for the development of vaccines and biopharmaceutical products.

SBL Vaccin Cholera Vaccine Production

In the second quarter of 2003 the Swedish vaccine producer, SBL Vaccin AB, brought on-line a major extension and upgrade

SCA Pharmaceuticals’ Manufacturing Facility, Windsor, Connecticut

In November 2017, US-based pharmaceutical company SCA Pharmaceuticals officially opened a manufacturing facility in Windsor, Connecticut.

SCG Cell Therapy’s manufacturing facility and R&D centre, Singapore

The manufacturing system utilised in the facility has been accredited by the HSA and the FDA for clinical trials.

Schering-Plough Production and R&D Facilities

Schering-Plough has continued to capitalise on its investment program into facilities based in Singapore. The company cu

SCHOTT Pharmaceutical Packaging Plant Expansion, Zavolzhe

SCHOTT opened the first GMP-compliant pharmaceutical packaging production facility in Russia in May 2011. The plant is located at Zavolzhe near Nizhny Novgorod city in Russia.

SCHOTT Pharmaceutical Plant Expansion

SCHOTT Pharmaceutical Packaging operates a cGMP manufacturing plant in Lebanon Valley Business Park, Pennsylvania, US.

Science Research and Innovation Facility, University of Windsor

In December 2018, the University of Windsor officially opened a new science research and innovation facility (SRIF) at its campus in Ontario, Canada.

Scientia Clinical Research Facility, University of New South Wales (UNSW)

Construction of the Scientia Clinical Research facility at the Randwick Hospitals campus of the University of New South Wales (UNSW) began in November 2014.

ScinoPharm Bulk Pharmaceutical Plant, Tainan County, Taiwan

The ScinoPharm bulk pharmaceutical plant is located at the Tainan Science Industrial Park in Shan Hua, Tainan County in southern Taiwan.

Scorpion Biological Services’ Large Molecule Biomanufacturing Facility in Manhattan, Kansas, US

Scorpion Biological Services’ new CDMO facility in Manhattan, Kansas, will focus on biodefence.

Scripps Prebys Cardiovascular Institute, California

The Scripps Prebys Cardiovascular Institute was opened for patient care in March 2015 after around four years of construction.

Seagen’s Biologics Manufacturing Facility, Everett, Washington

Seagen will build a facility in Everett, Washington, by 2024 to expand its cancer medicine manufacturing capabilities.

Searle Pharma Medication Production Plant, Moscow

In 2000 Searle Pharma (part of Pharmacia which combined/merged with Pfizer in April 2003) opened a $30m medication p

Seqens’ Boston R&D Centre, Devens, Massachusetts, USA

Seqens has opened a $5m facility to develop and manufacture drugs and therapeutics in Devens, Massachusetts.

Seqirus Vaccine Manufacturing Facility Expansion, North Carolina, US

Seqirus’ manufacturing facility expansion in Holly Springs aims to enhance its ability to respond to an influenza pandemic.

Seqirus’ Influenza Vaccine Manufacturing Facility, Melbourne

Seqirus, an influenza vaccine maker, is building a new cell-based influenza vaccine manufacturing facility in Melbourne, Australia.

Serologicals Corporation Biotech Production Plant

Serologicals Corporation finished the construction of a new biotechnology production facility in Lawrence, Kansas, US, i

Servier Paris-Saclay Research Institute, Paris

Servier Pharmaceuticals is constructing Servier Paris-Saclay research institute, a new research and development hub in the Paris-Saclay cluster, France, which is one of the world’s top eight invention clusters.

SGS Life Science Services Laboratory Facility, Mumbai, Maharashtra

In January 2012, SGS opened a new life sciences laboratory in Navi Mumbai, Maharashtra, India. It is SGS' second facility in India, the first being located in Chennai, Tamil Nadu.

Shanghai CP Guojan API Production Suite, Shanghai

Shanghai CP Guojian Pharmaceutical Co Ltd (CPGJ) is a biopharmaceutical company that was formed in January 1998. The com

Shanghai Roche Pharmaceuticals, Shanghai

Roche operates in China as Shanghai Roche Pharmaceutical Co Limited, which is a highly successful joint venture operated

ShangPharma Manufacturing and Pre-Clinical Research Facility, Shanghai

China-based pharmaceutical outsourcing partner ShangPharma has signed a deal with the Qidong Biopharma Industrial Zone in Qidong, China, to build a biologics manufacturing and pre-clinical research facility.

ShangPharma Pilot Plant Facility, Fengxian

China-based contract research organisation ShangPharma Corporation launched phase one of a new pharmaceutical developme

Sharp Packaging Solutions Facility Expansion, Pennsylvania

In June 2016, pharmaceutical packaging company Sharp Packaging Solutions officially opened its Centre of Excellence for speciality, biological and cold chain packaging in Allentown, Pennsylvania.

SHINE Medical Isotope Production Facility, Janesville, Wisconsin

US-based nuclear technology company SHINE Medical Technologies is building a medical isotope production facility in Janesville, Wisconsin.

SHINE Medical Isotope Production Facility, Veendam, Netherlands

US-based radiopharmaceutical company SHINE Medical Technologies is to build a medical isotope production facility in Veendam, Netherlands. The facility is intended to provide a reliable, flexible supply of a range of vital medical tracers and cancer treatment elements for customers in Europe.

Shionogi Pharmaceutical Research Facility, Osaka

Shionogi & Co's new pharmaceutical research facility is located in Toyonaka City in Osaka, Japan. The new facility was opened in August 2011. It is equipped with drug discovery research laboratories and laboratory equipment, as well as information technology capabilities.

SHL Medical Autoinjector Manufacturing Facility, South Carolina, USA

SHL Medical’s new facility in North Charleston, South Carolina, is expected to start operations by Q2 2024.

Shonan Research Center

Shonan Research Center is a new drug discovery and development centre located in Fujisawa City, Kanagawa prefecture, Japan.

Sidra Medical and Research Center, Doha

Located in Doha, Qatar, Sidra Medical and Research Center will be an ultramodern, all-digital academic medical centre, designed and planned to the highest international standards in technology, science and patient care.

Siegfried Holding Facility

Alliance Medical Products (AMP) operates a state-of-the art cGMP facility in Irvine, California, US.

Siemens Healthineers Facility Expansion, Walpole, Massachusetts

In June 2017, Germany-based medical technology company Siemens Healthineers began an expansion and refurbishment of its laboratory diagnostic manufacturing facility in Walpole, Massachusetts.

Sinergium Biotech Antigen Production Plant, Buenos Aires

Argentina-based biopharmaceutical company Sinergium Biotech has announced it will start building a primary antigen production plant in the town of Garin, located in Buenos Aires province.

SMC Group’s Pharmaceutical Development Services Facility, Cambridge, UK

SMC Group has opened a facility in Cambridge, UK, to offer pharmaceutical development services to customers.

Sofrigam Cold Chain Manufacturing Facility, Arras

Sofrigam opened its factory in Arras, France, in January 2008. The factory is used to test and manufacture temperature-controlled logistics packaging for the European market, and produces cold chain solutions for companies including GSK, Astra Zeneca and Pfizer.

Solagran Biotech Plant, Tomsk, Siberia, Russia

Solagran Ltd is a Melbourne, Australia-based biotechnology company. It has a portfolio of highly potent low side-effect,

Sorrel Medical’s New Manufacturing Facility, Netanya

Wearable drug delivery devices manufacturer Sorrel Medical opened a new manufacturing facility in Israel in July 2020.

South Australian Health and Medical Research Institute (SAHMRI), Adelaide

The South Australian Health and Medical Research Institute (SAHMRI) at North Terrace in Adelaide, South Australia, was officially opened in November 2013.

South Texas Research Facility

The University of Texas Health Science Center (UTHSC) opened the new South Texas Research Facility (STRF) at its campus in San Antonio, US, in October 2011.

Spark Therapeutics’ Gene Therapy Innovation Center, Philadelphia, USA

Spark Therapeutics will build Gene Therapy Innovation Center on Drexel’s University City Campus, Philadelphia, by 2026.

Spaulding Clinical Research Facility

Spaulding Clinical Research completed a renovation of its clinical research facility on 20 August 2010. Located in Wes

STA Pharmaceutical’s Manufacturing Facility, Changzhou

STA Pharmaceutical (STA), a subsidiary of WuXi AppTec, opened its new large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in Changzhou, China, in January 2020.

Stada Arzneimittel Supply Chain and Packaging Facility, Turda, Romania

Stada will build a supply-chain hub in Turda, Romania, with an investment of more than €50m ($51.9m).

STC Biologics’ GMP Manufacturing Facility, Massachusetts, US

In April 2019, STC Biologics opened a single-use mammalian good manufacturing practices (GMP) facility in Newton, Massachusetts, US.

Stelis’ Biologics Manufacturing Facility Expansion, Bangalore

Stelis BioSource™, a division of Stelis Biopharma, is expanding its biologics manufacturing facility located in Bangalore, India.

Stirling Pharma Pharmaceutical Production

Stirling Pharma's pharmaceutical plant in North Sydney, Nova Scotia, Canada, on a 300-acre business park was commissione

Stratophase Chip Production Facility

Stratophase relocated to a new facility in Romsey, UK, on 14 July 2010. The new facility is much larger than the old

Sumitomo Pharmaceutical Manufacturing Plant, Ibaraki City, Japan

In 2000, Sumitomo Pharmaceutical Company completed the construction of a manufacturing plant in 2000 in Ibaraki city, near Osaka, Japan.

SurModics Pharmaceuticals cGMP Manufacturing and Development Facility

SurModics Pharmaceuticals launched a new cGMP facility for manufacturing and development on 21 January 2010. Located at


Taiyo Pharmaceutical Industry, Contract Manufacturing Plant

Taiyo Pharmaceutical Industry (Taiyo Yakuhin) is one of the foremost contract pharmaceutical manufacturing and packaging

Takara Bio’s Center for Gene and Cell Therapy Processing II, Shiga

Takara Bio opened its new facility, the Center for Gene and Cell Therapy Processing II (CGCPII), in Shiga, Japan.

Takeda Bulk API Plant

Takeda Chemical Industries Ltd broke ground on the construction of a new active pharmaceutical ingredients (API) plant i

Takeda Pharmaceutical High-Containment Production Facility, Dublin

Japan-based pharmaceutical company Takeda has started building a high-containment production facility at its existing site at the Grange Castle Business Park in Dublin, Ireland.

Takeda Pharmaceutical Manufacturing Facility, Oranienburg

Japan-based drugmaker Takeda Pharmaceutical Company has inaugurated a pharmaceutical production facility at its existing site in Oranienburg, Germany.

Takeda Pharmaceutical Manufacturing Plant, Yaroslavl, Russia

In September 2012, Japanese pharmaceutical company Takeda Pharmaceutical finished building a manufacturing facility at Yaroslavl, Russia.

Takeda’s Dengue Vaccine Manufacturing Plant, Singen, Germany

Takeda Pharmaceuticals opened a vaccine manufacturing plant in Singen, Germany, in November 2019, for the production of its dengue vaccine candidate, TAK-003.

Takeda’s Plasma-derived Therapies Manufacturing Facility, Japan

Takeda will open a new plasma-derived therapy manufacturing facility by investing Y100bn ($755.8m) in Osaka by 2030.

Taysha’s Gene Therapy Manufacturing Facility, Durham, North Carolina

Taysha Gene Therapies will build a new current Good Manufacturing Practices (cGMP) gene therapy manufacturing facility in Durham, North Carolina, US to support preclinical, clinical and commercial cGMP production of its broad gene therapy pipeline drugs.

Teknova’s Life Sciences Reagents Manufacturing Facility, Hollister, California, USA

Alpha Teknova opened a state-of-the-art modular manufacturing facility in Hollister, California, for GMP-grade production.

Teligent’s Manufacturing and R&D Complex Expansion, Buena, New Jersey

In 2017, Teligent completed an expansion of its Food and Drug Administration (FDA) approved manufacturing and research and development (R&D) complex in Buena, New Jersey.

Tergus Pharma’s Commercial Manufacturing Facility, North Carolina

Tergus Pharma opened a new pharmaceutical manufacturing facility and headquarters in Research Triangle Park in Durham in May 2021.

Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm

Teva Pharmaceuticals opened a new sterile manufacturing facility at Ulm city in the Blaubeuren-Weiler state of Germany in July 2013.

Texas Medical Centre’s TMC³ Life Science Campus, Houston, Texas

Texas Medical Centre (TMC) began building the 37-acre TMC³ life science campus in Houston, Texas, in August 2021.

The Center for Breakthrough Medicines’ Cell and Gene Therapy Manufacturing Facility, King of Prussia

The Center for Breakthrough Medicines, a contract development and manufacturing organisation (CDMO), is developing the world’s largest and most advanced single-point facility for cell and gene therapy manufacturing in King of Prussia, Pennsylvania, US.

The Centre for Cancer Immunology, University of Southampton

The University of Southampton’s Centre of Cancer Immunology is situated at Southampton General Hospital.

The Commercialization Center for Innovative Technologies (CCIT)

The Commercialization Center for Innovative Technologies (CCIT) is a major incubation facility in the US catering to co

The Francis Crick Institute, London

The Francis Crick Institute (previously known as the UK Centre for Medical Research and Innovation, or UKCMRI), is an interdisciplinary medical research centre in London, UK.

The GreenVax Project

The GreenVax project is a bio-therapeutic production facility currently under construction in the Texas A&M Health Sc

The Jackson Laboratory for Genomic Medicine, Connecticut

The Jackson Laboratory (JAX), a non-profit mammalian genetics research organisation based in the US, started construction on a new laboratory facility for genomic medicine at the University of Connecticut Health Center (UCHC) campus in Farmington, in January 2013.

The Legacy Centre, Dallas, Texas, US

The Legacy Centre is a new corporate campus and dedicated organ and tissue recovery centre in Dallas, Texas. Opened by Southwest Transplant Alliance (STA) in March 2021, it is the latest facility dedicated to organ and tissue recovery in the US.

The Life Sciences Facility, Clemson University, South Carolina

The new life sciences facility at the Clemson University campus in South Carolina, the US, was opened in February 2013.

The London Cancer Hub, Sutton

The London Cancer Hub is a facility for cancer research and treatment located in Sutton, London.

The Maurice Wohl Clinical Neuroscience Institute

The Maurice Wohl Clinical Institute is located within the psychiatry institute of King’s College London’s Denmark Hill campus.

The National Institute for Bioprocessing Research and Training (NIBRT)

The National Institute for Bioprocessing Research and Training (NIBRT) is a state-of-the-art, multi-functional building specifically built to serve the needs of Irish bioprocessing industry by providing a world-class platform for research and training.

The Pears Building, Royal Free Hospital, London, UK

The Pears Building is a new ultra-modern research facility located at the Royal Free Hospital campus in north London, UK. The £60m ($85.1m) building was jointly developed by the Royal Free Charity, the University College London (UCL) and the Royal Free London NHS Foundation Trust.

The Rockefeller University Campus Expansion, New York

Located in York Avenue, New York and established in 1901, Rockefeller University is the first biomedical research institute established in the US.

The Wisconsin Institutes for Discovery, Wisconsin

The Wisconsin Institutes for Discovery building is an innovative biomedical research centre located within the Universit

Thermo Fisher Scientific’s Cell Therapy Facility, US

The facility forms part of Thermo Fisher’s global pharma services network, which includes more than 15 sites.

Thermo Fisher Scientific’s Sterile Drug Facility, Singapore

The new sterile drug facility will improve the delivery of critical vaccines and therapies in the Asia-Pacific market.

Thermo Fisher Scientific’s Biologics Manufacturing Facility, Lengnau, Switzerland

The state-of-the-art fully automated facility is built on a 1.5 million square feet site and comprises three buildings, including Building A, B and C.

Thermo Fisher Scientific’s New Manufacturing Facility, Lenexa, Kansas, US

Thermo Fisher Scientific opened a new manufacturing facility in Lenexa, Kansas to meet the increasing demand for viral transport media (VTM) being used in Covid-19 testing in the US.

Thermo Fisher Scientific’s Plasmid DNA Manufacturing Facility, Carlsbad, California

Thermo Fisher Scientific opened a plasmid DNA manufacturing facility in Carlsbad, California, in July 2021.

Thermo Fisher Scientific’s Viral Vector Manufacturing Facility, Plainville, Massachusetts

Thermo Fisher Scientific opened a manufacturing facility for viral vectors in Plainville, Massachusetts, in August 2022.

Thermo Fisher’s Biologics and Sterile Drug Manufacturing Facility, Hangzhou

Thermo Fisher Scientific (Thermo Fisher) will establish a new pharmaceutical services facility for integrated biologics and sterile drug development and manufacturing in Hangzhou, China.

Torrent Pharmaceuticals and Novo Nordisk Insulin and Parenteral Facility

In December 2017, Torrent Pharmaceuticals and Novo Nordisk India opened a greenfield insulin and parenteral facility at Torrent’s parenteral facility in Indrad, Gujarat, India.

Touchlight’s DNA Manufacturing Facility, London, UK

Touchlight’s DNA manufacturing facility is based at the Morelands and Riverdale Buildings on the banks of the River Thames, within Hampton, London.

Translational Research Institute (TRI), Brisbane, Australia

The Translational Research Institute (TRI) is a medical research facility located at the Princess Alexandra Hospital campus in Woolloongabba in Brisbane, Australia.

Tripharm’s Pharmaceutical Manufacturing Centre, North Carolina

TriPharm Services, a contract development and manufacturing organisation (CDMO), is developing a pharmaceutical manufacturing centre in Morrisville, North Carolina, US.

Trygg Pharma’s Seal Sands Bulk Pharmaceuticals Facility, Teesside, UK

In April 2000, Lundbeck Pharmaceuticals was awarded contracts for the construction of a bulk pharmaceutical facility in Seal Sands, Teesside, UK.


UBC Pharmaceutical Sciences Building, Vancouver

The University of British Columbia (UBC) is constructing a facility for the Faculty of Pharmaceutical Sciences in Vancouver, in the state of British Columbia in Canada.

UCB Biologics Pilot Plant, Braine-l’Alleud

Brussels-based biopharmaceutical company Union Chimique Belge (UCB) broke ground for a new biotechnology pilot facility

UCB’s Gene Therapy Facility, Braine l’Alleud, Wallonia, Belgium

UCB’s new gene therapy facility in Braine-l'Alleud is expected to begin operations in 2024.

UCSF Robotic Pharmacy, San Francisco

The University of California San Francisco (UCSF) has built an automated hospital pharmacy at its new medical centre at Mission Bay, San Francisco. The system is capable of dispensing medication automatically. It utilises robotic technology to prepare and track medications.

UCSF Weill Neurosciences Building, San Francisco, California

The new site serves as the Weill Neurohub headquarters and a global centre for neurological and psychiatric disease researchers.

Ultragenyx’s Gene Therapy Manufacturing Facility, Bedford, Massachusetts, USA

Ultragenyx opened a new state-of-the-art gene therapy manufacturing facility in Bedford, Massachusetts, US.

Umoja Biopharma’s CAR-T Immunotherapies Manufacturing Facility, Louisville, Colorado

Umoja Biopharma is developing a state-of-the-art facility in Louisville for manufacturing next-generation CAR T immunotherapies.

Unilife Corporation Commercial Production Facility

Unilife Corporation inaugurated a commercial manufacturing facility in December 2010. The facility, located in York, Pen

Univercells’ Cell and Gene Therapy Manufacturing Facility, Jumet, Belgium

Univercells is developing a facility in Jumet, Belgium for the production of cell and gene therapies.

University of Maryland Biopark

The University of Maryland in Baltimore has developed a state-of-the-art BioPark on the urban campus of the university.

University of Maryland Health Sciences Research Facility III (HSF III), Baltimore

Construction of a new biomedical research facility known as Health Sciences Facility III (HSF III) began at the University of Maryland campus in September 2013.

University of Washington (UW) Medicine Research Complex, Seattle

The new medical research complex at University of Washington (UW) School of Medicine in South Lake, Seattle was completed in March 2013.

Upperton’s Pharmaceutical Development and GMP Manufacturing Facility, Nottingham, UK

Upperton’s new development and manufacturing facility will be developed with a £15m ($18.7m) investment by the end of 2023.

Upsher-Smiths’ Pharmaceutical Manufacturing Facility, Minnesota, USA

Upsher-Smith's new manufacturing facility in Maple Grove offers contract manufacturing and packaging capabilities.

UTEP Interdisciplinary Research Building, Texas

The University of Texas at El Paso (UTEP) has started building an interdisciplinary research building at 500 West University Avenue in Texas.


Vaccines Manufacturing Innovation Centre, Oxfordshire

Vaccine Manufacturing Innovation Centre (VMIC) in Oxfordshire will become the first-ever facility dedicated to the development and manufacturing of vaccines in the UK, upon its completion.

Van Andel Institute Cancer Research Facility

The Van Andel Institute completed a $178m phase II expansion on its cancer research facility in downtown Grand Rapi

VaxGen Biopharmaceutical Manufacturing Plant

VaxGen opened a new biopharmaceutical manufacturing facility in South San Francisco, California, US in June 2003. The fa

Vaxxas Biomedical Manufacturing Facility, Australia

Vaxxas' biomedical manufacturing facility in Australia will manufacture vaccines based on the company’s novel HD-MAP technology.

Velesco Pharmaceutical New Facility

Velesco Pharmaceutical is a provider of analytical procedure development, drug formulation, stability testing and consul

Vertex Pharmaceuticals’ Boston Campus

Massachusetts-based biotechnology company Vertex Pharmaceuticals (Vertex) is currently relocating its headquarters from Cambridge to Fan Pier, on the Boston Waterfront.

Vetter Pharma-Fertigung, Contract Manufacturing Facility, Ravensburg

Vetter is a leading contract development manufacturing organisation that specialises in the aseptic filling of liquid and lyophilised drugs for international biotechnology and pharmaceutical companies.

Vetter Small-Scale Fill-Finish Facility, Chicago

Vetter Pharma's new small-scale fill-finish facility is in Skokie, a suburb of Chicago. Located at the Illinois Science

Vetter’s New Production Facility, Ravensburg, Germany

Germany-based contract development and manufacturing organisation (CDMO) Vetter has started building a production facility at Schuetzenstrasse, Ravensburg.

Vetter’s Skokie Manufacturing Facility Expansion

Vetter, a contract development and manufacturing organisation (CDMO) based in the US, is expanding its small-scale fill-finish site located in Skokie, Illinois, Chicago, US.

VGXI’s New Headquarters and Manufacturing Facility, Conroe, Texas

Contract manufacturer VGXI is due to open its headquarters and manufacturing facility in Conroe, Texas, in 2022.

Vibalogics’ Virotherapy Manufacturing Facility, Boston, Massachusetts

Vibalogics’ GMP-compliant virotherapy manufacturing plant in Boston, Massachusetts, was opened in December 2021.

Viralgen’s Medicinal Products and Gene Therapies Manufacturing Facility, San Sebastian, Spain

Viralgen has received cGMP certification for clinical and commercial rAAV manufacturing at its new facility in San Sebastian.

Virginia Cancer Specialists (VCS) Research Facility, Virginia

In June 2017, Virginia Cancer Specialists (VCS) opened a Phase I clinical research facility in Fairfax, Virginia.

Viropro cGMP Biomanufacturing Facility

Alpha Biologics, a contract biomanufacturing service provider, commissioned a new cGMP biomanufacturing plant in April

Vivalis R&D Facility

Vivalis opened a new R&D facility in Saint-Herblain, Nantes, France on 28 June 2010.  The facility, located adjacen

VIVEbiotech’s Lentiviral Vector Manufacturing Plant, San Sebastian

VIVEbiotech, a good manufacturing practice (GMP) contract development and manufacturing organisation (CDMO) based in Spain, has opened a lentiviral vector manufacturing plant in Spain to meet demand from the cell and gene therapy industry.


Wacker Chemie Biologics Production Facility

Wacker Chemie inaugurated a new production facility at its Jena site on 8 March 2010. Located approximately 90km south-w

WACKER mRNA Competence Centre, Halle, Germany

The mRNA Competence Centre at the Weinberg Campus is intended to help the German government prepare for future pandemics.

Wallace Wurth Biomedical Research Centre

The Wallace Wurth Building is the most recognisable building at the Kensington campus at the University of New South Wales (UNSW) in Sydney, Australia.

Wasdell Group Pharmaceutical Packaging Facility, Dundalk

In July 2019, the UK-based Wasdell Group (Wasdell) opened a state-of-the-art pharmaceutical packaging plant in Dundalk, Ireland. Built with an estimated cost of €30m ($35.77m), the facility is Wasdell’s first plant outside the UK.

Weill Cornell Belfer Research Building, New York

The Weill Cornell Medical College at Cornell University opened a new translational research building in its premises in January 2014.

West Pharmaceutical Services Pharmaceutical Packaging Plant, Sri City, Andhra Pradesh

West Pharmaceutical India Packaging opened a new manufacturing plant at the special economic zone (SEZ) in Sri City, an integrated business area, in India.

Williamson Translational Research Building, Geisel School of Medicine

Construction of the Williamson Translational Research Building (WTRB) at the Geisel School of Medicine began in June 2013 and was completed in August 2015.

Wistar Institute’s Biomedical Research Facility Expansion, Philadelphia

The Wistar Institute is the first biomedical research institute in the US and Philadelphia's first NCI-designated cancer centre. It opened a newly expanded biomedical research building named Robert and Penny Fox tower in September 2014.

WuXi Biologics’ Biologics Manufacturing Centre, Shijiazhuang, China

WuXi Biologics is constructing an integrated biologics manufacturing centre of excellence (MFG8) in the city of Shijiazhuang, Hebei, North China, that will be one of the biggest of its kind in the region, when completed.

WuXi Biologics’ Biologics Manufacturing Facility, Ireland

WuXi Biologics’ Dundalk facility in Ireland has one of the largest single-use bioreactor capacity in the world.

WuXi Biologics’ Biologics Production Facility, Massachusetts, US

In June 2018, Chinese biopharmaceutical company WuXi Biologics announced the development of a new production facility in Worcester, Massachusetts, US.

WuXi Biologics’ Perfusion Biologics Manufacturing Facility, Wuxi City

In September 2016, China-based biopharmaceutical company WuXi Biologics completed the first phase of development for a perfusion biologics production plant in Wuxi City, China.

WuXi STA’s Pharmaceutical Manufacturing Campus, Delaware, USA

WuXi STA’s pharmaceutical manufacturing campus in Delaware, US, is expected to open in 2025.

Wyckoff Active Pharmaceutical Ingredient Plant, Michigan, US

In Q1 1998, Wyckoff started a $6m internal expansion at its site in South Haven, Michigan.


Xcellerex FlexFactory Biomanufacturing Facility

Xcellerex commissioned its biomanufacturing facility in in Marlborough, Massachusetts, US, in September 2010. It is seco


Yposkesi’s Cell and Gene Therapy Facility, Corbeil-Essonnes, France

France-based contract development and manufacturing organisation (CDMO) Yposkesi is building its second commercial facility to manufacture cell and gene therapies at its campus in Corbeil-Essonnes, France.

Ypsomed Production Facility, Schwerin, Germany

Ypsomed built a new production facility for medical technology within the Schwerin industrial park in Germany.


Zayed Centre for Research into Rare Disease in Children, London

Construction of the Zayed Centre for Research into Rare Disease in Children in London, UK, is expected to begin in March 2016.

Zoetis’ Animal Vaccine Research and Manufacturing Complex, Suzhou

In April 2018, global animal health company Zoetis began building an animal vaccine manufacturing and research complex in Suzhou, China.